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ABSTRACT
Stroke is one of the leading causes of death and a major cause of disabilities in adults. More than half 
of stroke victims suffer some type of disability, ranging from different levels of minor weakness in a 
limb to a complete loss of mobility. Currently, treatment of stroke requires a stringent rehabilitation 
programs. Nevertheless, two thirds of all patients will still have some type of difficulty with regular 
daily activities. Recent experimental findings raise the possibility that functional improvement after 
stroke may be achieved through neuronal replacement by endogenous neural stem cells (NSCs) re-
siding in the adult brain. Therefore, additional understanding of the properties of NSCs will help to 
identify their optimal potential in cell-based therapy. Neurotrophic factors are a family of proteins 
that are important in neuronal development and function, and have been studied as possible treatments 
for ischemic brain injury. In addition to Brain-Derived Neurotrophic Factor (BDNF) and Glial cell 
line-Derived Neurotrophic Factor (GDNF), Mescenphalic Astrocyte-Derived Neurotrophic Factor 
(MANF) and Cerebral Dopamine Neurotrophic Factor (CDNF), that form a distinct family of 
evolutionary conserved proteins with neuroprotective effects, have potential for the treatment of 
stroke. While MANF has been shown to protect cortical neurons from death in a rodent model of 
ischemic brain injury, the effects of post-stroke MANF administration on cellular processes during 
the recovery phase are poorly understood. To shed light on the possible regenerative potential of 
MANF for the injured brain, we need to first investigate the roles of endogenous MANF in neural 
stem cells (NSC) under a normal or pathological conditions. We developed and optimized a work 
platform for studying the regulation and effect of MANF on biological properties of NSCs and corti-
cal development. Our findings reveal an important role of MANF in neurite outgrowth and neuronal 
migration in the developing cortex. In addition, we demonstrated that endogenous MANF has the
potential to protect NSCs against oxygen and glucose-deprivation conditions. Next, using neuro-
sphere and subventricular zone (SVZ) explant cultures, we further studied the effect of MANF ad-
ministration on cell differentiation and migration. We present the data that exogenously added MANF 
can induce neural/glial differentiation and promote cell migration out of SVZ explants. Also, utilizing
the advantage of NSCs as a target for MANF, we discovered that exogenous MANF can induce the 
phosphorylation of STAT3 in NSCs. Finally, we used the rat model of ischemic stroke to compare 
the effects of MANF and GDNF in neurogenesis after stroke. While injection of GDNF into lateral 
ventricle has a strong mitogenic effect to increase neurogenesis in SVZ, it does not induce migration 
of neuroblasts towards the ischemic area. In contrast, MANF facilitates the migration of neuroblasts 
towards the lesioned cortex. Regarding long-term infusions in the peri-infarct zone, both GDNF and 
MANF recruited the neuroblasts to the infarct area. However, only MANF accelerated functional 
recovery after stroke. In summary, this work has extended the knowledge of MANF’s capacity for 
neuronal differentiation as well as migration, and the regenerative capacity for its therapeutic use in 
further studies.
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11 INTRODUCTION
Stroke is the one of leading cause of death, accounting for 10% of all deaths, and a major 
cause of disabilities in adult (Lopez et al., 2006). More than half of stroke victims suffer 
some type of disability, ranging from different levels of minor weakness in a limb, to a 
complete loss of mobility in one side of the body. In Finland, stroke mortality has been 
declining to 8.9% of all deaths and is surpassed by cancer (Meretoja et al., 2011). Despite 
this, stroke incidence is strongly age-dependent and Finland has one of the most rapidly 
aging populations in Europe, with 17.2% of the population currently aged above 65 years
(Sivenius et al., 2009). If primary prevention does not improve, Finland faces a rapid 
growing number of stroke patients. Optimal treatment for stroke should be developed to 
satisfy future increases in demand and ensure the best functional recovery after stroke.
Current clinical treatment strategies for stroke primarily focus on removing the embolic 
clot to rescue cells from dying. The therapy for stroke is limited by a narrow therapeutic 
time window after onset of stroke, and lack of effective remedies for days after stroke
(Barkho and Zhao, 2011). Recent findings raise the possibility that functional 
improvement after stroke may be achieved through neural replacement by endogenous 
neural stem cells/neuronal progenitor cells (NSC/NPCs) residing in the adult brain, such 
as in the subventricular zone (SVZ). Using a filament-based middle cerebral artery 
occlusion (MCAO) model in adult rodents, many studies have shown that within the first 
week after a focal ischemic insult there is a pronounced loss of striatal and cortical 
neurons (Belayev et al., 1996; Kokaia and Lindvall, 2003). However, there is a major 
increase in NSC proliferation within SVZ indicating that ischemic injury increases 
endogenous regenerative processes. Increased NSC proliferation has also been seen in 
both the hippocampus and the SVZ after both trauma and seizures during the first week 
after injury, but the rates of proliferation return to normal after several weeks. In addition 
to increased number of NSC/NPCs in the SVZ, there is increased migration of NPCs 
from SVZ to damaged regions (Yamashita et al., 2006). The recruitment of NPCs to the 
lesioned site raises the possibility of new-generated neurons replacing apoptotic neurons
(Barkho and Zhao, 2011). However, in ischemic cortical stroke, very few adult-born 
2neurons in the ischemic cortex have been found, suggesting that the injured cortex is a 
nonpermissive environment for neuronal differentiation, either because of lack of 
survival cues, neurodifferentiation signals, or the presence of signals inhibitory for 
neurogenesis (Arvidsson et al., 2002).
Neurotrophic factors (NTFs) are proteins important for neuronal survival, regeneration 
and remyelination. Nerve growth factor (NGF) was the first neurotrophic factor 
demonstrated to be required for normal neuronal development (Airaksinen and Saarma, 
2002). Another effect of NGF is the induction of neurite outgrowth (Angelastro et al., 
2003) and potential clinical applications of this property, are being investigated, for 
instance, the use of the dorsal root ganglion cell together with NGF for regeneration of 
spinal ganglion neurons (Hu et al., 2005). Brain-derived neurotrophic factor (BDNF) is 
essential for the production of neurons from hippocampal progenitors, being required 
during proliferation to trigger neuronal fate (Bull and Bartlett, 2005). Moreover, BDNF is
implicated in the dentate gyrus in response to neurogenic stimulation by exercise and has 
a role in mediating the effect of antidepressant drugs on hippocampal neurogenesis (Jun 
et al., 2012). Furthermore, BDNF has been shown to reduce motoneuron death after 
axotomy in neonatal animals and in adults after ventral root avulsion (Kishino et al., 1997; 
Novikov et al., 1997). Intrathecal administration of BDNF reverses both soma atrophy 
and reduction of choline acetyl transferase in motoneurons. Glial cell line-derived 
neurotrophic factor (GDNF) is a potent survival factor for midbrain dopaminergic 
neurons and prevents motoneuron cell death following ventral root avulsion in adults
(Matheson et al., 1997). It also has a chemoattractant effect on neuronal precursor cells in 
the rostral migratory stream (d'Anglemont de Tassigny et al., 2015). Evidence exists that 
GDNF might directly affect peripheral nerve regeneration. Thus, neurotrophic factors 
such as NGF and BDNF delivered through an intracerebral route could become useful in 
therapeutic regimens. It is also envisioned that genetic engineering of NSCs that?
synthesize certain neurotrophic factors before transplanting or migrating into lesioned 
sites may augment the efficacy of both NSCs and neurotrophic factors in clinical 
situations.
3Other neurotrophic factors are less defined in the literature. Cerebral dopamine 
neurotrophic factor (CDNF) and mesencephalic astrocyte-derived neurotrophic factor 
(MANF), located at endoplasmic reticulum (ER) and secreted in response to ER stress, 
are proteins that constitute a novel, evolutionarily conserved neurotrophic factor family 
expressed in vertebrates and invertebrates (Lindholm et al., 2007; Lindahl et al., 2017).
The purpose of the present studies was to characterize the role of MANF on NSCs and its 
effects in neuronal differentiation, migration, and cortical development. Moreover, the 
neuroregenerative potential of MANF in a rat model of cortical stroke was explored.
42 REVIEW OF THE LITERATURE
2.1 Defining neural stem cells and their properties
As the central nervous system (CNS) develops, neural stem cells (NSCs) generated from 
neuroepithelium produce more specified neural restricted precursor cells and glial 
restricted precursor cells (Temple, 2001). Undifferentiated neural precursor cells 
differentiate and migrate to appropriate locations in which cells undergo further 
maturation; neural/glial cells become postmitotic, and neuronal cells send projections to 
appropriate targets and make synapses (Filous and Silver, 2016). As development 
proceeds, the number of NSCs is much diminished and by birth these cells represent only
a small fraction of dividing cells located in restricted regions of the brain. Coincident 
with this decrease, the number of progenitor cells increases gradually and more mature 
differentiated cells can be identified as they migrate from the proliferating zones to their 
terminal locations. Throughout the CNS, neurogenesis is followed by gliogenesis which 
is followed in turn by the development of neuronal connections and subsequent 
myelination of axons (Borrell and Reillo, 2012). These complex changes ultimately result 
in the formation of the adult brain which undergoes, under non-pathological conditions, 
little new neuronal augmentation, except for the hippocampus and olfactory bulb.
2.1.1 The cellular properties of multipotent neural stem cells
The neural stem cells have the car??????????????????????????????????the ability to self-renew 
and to generate differentiated progeny (Anderson, 2001). During early mammalian 
embryogenesis, the newly specified neuroectodermal cells which make up the neural 
plate and neural tube are known as neuroepithlial (NEP) cells (Haubensak et al., 2004; 
Wilson and Houart, 2004; Dwyer et al., 2016). In vivo, NEP cells have been observed to 
undergo multiple rounds of symmetrical cell division for expansion of the progenitor 
pool. In addition, NEP cells can undergo asymmetrical division in which one NEP 
daughter cell and one nascent neuron are produced (Miyata et al., 2004; Kon et al., 2017).
These first-born neurons then migrate away from the proliferative ventricular zone to the 
mantle zone. Shortly after the onset of neurogenesis, NEP cells begin to acquire a glial 
5identity, forming a new neural stem cell population such as radial glial cells (RG cells)
(Howard et al., 2008; Kazanis et al., 2008). Initially, RG cells were identified as 
scaffolding for newly generated migratory neurons (Heng et al., 2010), but now they are 
thought to be the primary progenitors of most neurons throughout the CNS and also to 
give rise, via lineage-restricted intermediate precursors, to the two main glial cell types:
astrocytes and oligodendrocytes (Gritti and Bonfanti, 2007). In the nervous system, there 
is a distinct progression of lineage differentiation whereby RG cells first give rise to 
neurons and later to astrocytes and oligodendrocytes (Martynoga et al., 2012). NEP and 
RG cells can be cultured in vitro as neurospheres in the presence of fibroblast growth 
factor (FGF2) as well as epidermal growth factor (EGF), and in cultures they are 
multipotent and exhibit a self-renewal capacity (Ciccolini and Svendsen, 1998; Tropepe 
et al., 1999; Yoon et al., 2004; Chen et al., 2015b).
Following the transition to the RG fate, some progenitor cells begin to divide 
asymmetrically to generate a RG cell and another differentiated daughter cell, which 
migrates away from the apical progenitor domain and begin neuronal differentiation
(Martynoga et al., 2012). In the forebrain, the cell lineages that produce neurons are very
complex, and there are fate-restricted progenitor stages between stem cells and 
postmitotic cells. These intermediate cells have been called basal progenitors (BPs). They 
are generated in the developing telencephalon by asymmetric division from RG cells
(Haubensak et al., 2004). In the dorsal telencephalon, which gives rise to the cerebral 
cortex, BPs divide symmetrically to generate two neurons and are thought to generate 
most cortical projection neurons, including early-born neurons in deep cortical layers and 
late-born neurons in superficial cortical layers (Miyata et al., 2004; Farkas and Huttner, 
2008; Jiang and Nardelli, 2016). Thus, BPs appear to be unipotent and incapable of self-
renewal in vivo, however, their potential has not been conclusively analyzed in vitro.
It is now commonly accepted that the adult mammalian brain is not just a static 
postmitotic organ, but also contains populations of cells with stem cell potential, although 
each population is distinct in regard to its differentiation capacity (Kirby et al., 2015).
Adult neural stem cells within the SVZ are descendants of RG cells which line the 
6embryonic lateral ventricle (Kriegstein and Alvarez-Buylla, 2009). In rodents as shown in 
Figure 1, the predominant role of the SVZ stem cells is to generate new neurons which 
tangentially migrate through the rostral migratory stream (RMS) to the olfactory bulb 
where they differentiate into interneurons (Sun et al., 2010). The adult SVZ harbors four 
classes of cells: Type A, B, C and ependymal cells (Duan et al., 2008; Gil-Perotin et al., 
2009). Ependymal cells are relatively quiescent in vivo but retain the ability to enter the 
cell cycle and may respond to injury by proliferation (Kempermann et al., 2004). Type B 
cells undergo asymmetric cell division to generate a transient amplifying population of 
rapidly dividing SVZ cells (type C cells) that in turn generate migratory neuroblasts (type 
A cells) which migrate along the RMS to the olfactory bulb (Doetsch et al., 1999b; 
Doetsch et al., 1999a; Jessberger, 2016). In addition to the germinal zone of the SVZ, 
continued neurogenesis has been described in the granular layer of dentate gyrus (DG)
(Kuhn et al., 1996; Horowitz and Villeda, 2017). Progenitor cells are found along a thin 
strip of cells, referred to as the subgranular zone (SGZ), between the hilar regions and the 
granular cell layer (Gage et al., 1998; Guo et al., 2012). It has been shown that these cells 
have diverse functions in memory, learning, and cell replacement (Veeraraghavalu and 
Sisodia, 2013; Amrein, 2015). Furthermore, ischemic insults have been demonstrated to 
trigger neurogenesis from neural stem or progenitor cells in the SVZ of the lateral 
ventricle and dentate gyrus (DG) of the hippocampus (Kokaia and Lindvall, 2003; 
Kojima et al., 2010). Although the transcriptional and cellular events that maintain NSC
identity in adult brain remain elusive, evidence suggests that the underlying mechanisms 
probably share a common, early embryonic gene expression program.
7Figure 1. Schematic representation of the localization and cellular composition of the adult subventricular 
zone in the rodent brain. Neuroblasts generated in the SVZ niche migrate to the olfactory bulb and 
differentiate into granular and periglomerular GABAergic interneurons (yellow sphere). SVZ astrocytes in 
this region (B, blue) are stem cells which generate migrating neuroblasts (A, red) destined for the olfactory 
bulb via a rapidly dividing transit-amplifying cell (C, green). Region in box is expanded at right to show 
the relationship of cells in this region and some elements of the SVZ niche and RMS. Multi-ciliated 
ependymal cells (E, grey) line the walls of the lateral ventricle. Chains of neuroblasts (A cells) travel 
through tunnels formed by processes of SVZ astrocytes. Transit-amplifying cells are found in small clusters 
adjacent to the chains. Signals released from axons (pink) regulate proliferation and survival in this region. 
A specialized basal lamina (BL, black) extends from perivascular cells and contacts all cell types. 
Endothelial cells, blood vessels (BV) and the basal lamina are all likely key components of the niche.
Modified from (Quinones-Hinojosa et al., 2006; Riquelme et al., 2008)
2.1.2 Self-renewal/proliferation of NSCs 
Self-renewal and maintenance of NSCs in the SVZ and SGZ niches are mediated by 
attachment and various signals emanating from the endothelial cells of blood vessels and 
the specialized basal lamina (Williams and Lavik, 2009)???-catenin and cadherins play a 
role in maintenance of NSCs, and Wingless-Type (WNT) signaling overexpression of ?-
catenin results in exaggerated proliferation of NSCs (Nelson and Nusse, 2004; Holowacz 
et al., 2011). In addition, the polycomb family transcriptional repressor Bmi-1 is 
important for NSC self-renewal but not for NSC survival or differentiation (Molofsky et 
al., 2005; Corley and Kroll, 2015). Another approach to maintain NSC in an 
8undifferentiated state is to keep proneural proteins in an inactivating state. For example, 
the SRY-related high-mobility groups (HNG)-box protein-1, SOX1, SOX2, and SOX3 of 
B1 group proteins of SOX family participate in maintaining the NSC pool by blocking 
proneural basic helix-loop-helix (bHLH) protein activity (Corley and Kroll, 2015).
Extracellular signals mediated by FGF2 and Notch1 are also crucial for maintaining the 
NSC pool and enhancing self-renewal within the SVZ niche (Hitoshi et al., 2004). Notch 
pathways are well established in promoting undifferentiated NSCs during developmental 
neurogenesis (Urban and Guillemot, 2014). In vitro self-renewal and proliferation can be 
meditated by high concentrations of mitogens, particularly EGF and FGF, in the culture 
medium (Hitoshi et al., 2004; Xu et al., 2017). In addition, ciliary neurotrophic factor 
(CNTF) augments self-renewal of neural precursors by promotion of Notch1 in vitro. The 
transforming growth facto?????????????????????????????the EGF receptor, may also have 
an influence on regulating proliferation of NSC/NPCs (Ahmed et al., 2009).
Neurotransmitters as well as their receptors and transporters, like GABA and glutamate, 
directly regulate NSC/NPCs proliferation by changes in DNA synthesis and alternations 
in intracellular calcium concentrations (Dammerman and Kriegstein, 2000; Poluch and 
Juliano, 2015). These effects may be area-specific since the NPC response to glutamate 
and GABA is different between VZ and SVZ. Moreover, dopamine can have a direct 
effect on proliferation, since its D2 receptor, is expressed in NSC/NPCs (Baker et al., 
2004; Sequerra, 2014). Moreover, hormones regulate NSC/NPC proliferation, since 
thyroid hormone increases ???????????????????????????????-receptor and regulation of c-
MYC expression (Lemkine et al., 2005). Furthermore, evidence indicates insulin-like 
growth factor 1 (IGF-1) promotes proliferation of NSCs in an estrogen-dependent manner
(Perez-Martin et al., 2003; Sakthiswary and Raymond, 2012).
Cell cycle regulation is also essential for maintaining a proliferative state. Activation of 
the RAS/RAF/MEK/ERK protein kinase pathway shortens cell cycle length and thus 
alters proliferation rate (Orford and Scadden, 2008) . This pathway operates through P53, 
retinoblastoma tumor suppression (Rb), and E2F families of proteins. Rb has a role in 
promoting proliferation by meditating telomerase signaling in a cell type specific manner
(Yoshikawa, 2000; Peng et al., 2012). The extracellular matrix is also important in 
9regulating NSC/NPC proliferation by directly affecting cell numbers or indirectly 
regulating the actions of growth factors. For example, integrins expressed by NSCs are 
activated by binding to extracellular matrix proteins which promote proliferation by 
activating intracellular phosphatidylinositol-3-kinase (PI3K) and AKT (Jacques et al., 
1998; Christie and Turnley, 2012).
2.1.3 Survival of NSCs 
The principle role of NSC apoptosis is to coordinate the number of proliferating cells, 
which will eventually affect brain size. Apoptosis is regulated by caspases and their
telecncephalic transcripts are essentially linked with NSC survival. Caspase-3 and 
caspase-9 as promoters of apoptosis seem to be essential for early forebrain development 
in a region or cell population specific manner (Raff, 1998; Kuan et al., 2000; Ceccatelli et 
al., 2004). Staurosporine activation or caspase inhibitor-mediated blocking of caspase-3
leads to apoptosis or excess survival of NSCs, respectively, thus implying a caspase-
dependent death pathway in NSCs. Apoptosis in NSCs via caspase activation can be 
blocked by activation of anti-apoptotic Bcl-2 (Hardwick and Soane, 2013). Another 
pathway that activates caspase-3 via Fas does not seem to cause apoptosis in NSCs. 
Antiapoptotic gene Bcl-X, which regulates neuron survival, is not involved with NSC 
apoptosis revealed by normal VZ after genetic manipulation. However, proapoptotic gene 
Bax, which is important for developmentally occurring neuronal death, seems to be 
important for naturally occurring apoptosis of adult NSCs through caspase and inositol 
1,4,5-triphosphate (IP3) activation. Extrinsic factors are also important in preventing 
apoptosis since neuroepithelial NSC survival is mediated by FGF, EGF, insulin/IGF, and 
activation of antiapoptotic Bcl-2 in vitro (Chen et al., 2007; Huang et al., 2007). Factors 
such as c-Jun and N-terminal kinase (Jnk) seem to affect NSC survival in a regional and 
temporal manner, since Jnks decrease apoptosis in neuroepithelial NSCs and promote it 
in the forebrain VZ (Kuan et al., 1999; Yamaguchi and Miura, 2013). NTFs also play a
role in NSC/NPC survival as shown by increases in apoptosis when the endogenous
BDNF receptor, TrkB, and neurotrophin-3 receptor, TrkC, mediated signaling are 
blocked by antibodies (Barnabe-Heider and Miller, 2003; van Velthoven et al., 2014).
This mechanism involves the downstream signaling target of Trks, PI3K and its adaptor 
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protein ShcA, suggesting an autocrine/paracrine action of neurotrophins in NSC/NPC 
survival (McFarland et al., 2006). Platelet-derived growth factor (PDGF) also acts 
through the PI3K pathway to promote survival of NPCs (Guillemot, 2007). The 
neurotransmitter glutamate promotes the survival of SVZ-derived NPCs (Brazel et al., 
2005), and in contrast, hydrogen peroxide and rotenone induce apoptosis in NSC/NPCs
(Lin et al., 2004; Wakai et al., 2014).
2.2 The processes of NSC differentiation
NSCs normally differentiate in multiple steps to produce the final cellular diversity in the 
mammalian CNS, starting from NSCs, through NPCs, to maturing terminally 
differentiated cell types including a vast variety of neurons, as well as astrocytes and 
oligodendrocytes. During cortical development, the generation of neurons and glia is 
temporally organized. Neocortical layer formation in particular occurs in a highly 
orchestrated manner. More recently, the discovery of genes that have layer and neuronal 
subtype specificity within the neocortex has made it possible to investigate the 
mechanisms underlying the specification of individual projection neuron subtypes. 
Finally, the onset of shaping of neuronal networks occurs during postnatal development 
and lasts to some extent throughout mammalian life.
2.2.1 The molecular mechanisms underlying neuronal differentiation
WNT signaling pathways play an important role in the NSC differentiation processes
after the switch to support neuronal differentiation of NSC/NPCs instead of proliferation
(Hirabayashi et al., 2004; Fernandez et al., 2016). WNT signaling is suggested to promote 
neurogenesis by directly activating proneural genes, Neurogenin1 and Neurogenin2 
(Ngn1 and Ngn2) in clonal NPC cultures (Machon et al., 2003; Israsena et al., 2004; 
Jiang and Nardelli, 2016).
Proneural genes encode bHLH transcription factors, which have key roles in 
neurogenesis. These genes which are expressed in the mammalian telencephalon include 
Mash1, Ngn1, and Ngn2, and are also expressed in neocortical NPCs as well as in basal 
ganglia NPCs (Bertrand et al., 2002; Ross et al., 2003; Ghareghani et al., 2017). The most 
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important function for proneural genes is to direct NSC/NPCs toward a neuronal fate 
instead of an astroglial fate. Another function of these genes is to convert neuroblasts into 
mature neurons. In vitro, proneural genes have been shown to promote neuronal lineage 
of NPCs by direct transcriptional activation of downstream genes such as NeuroD (Nieto 
et al., 2001; Sun et al., 2001; Parras et al., 2004; Jiang and Nardelli, 2016). Moreover, 
Ngn proteins interact with histone acetylase CBP/P300 to activate target genes and, with 
a component of chromatin remolding complex, Brg1, to promote neurogenesis in vitro
(Ge et al., 2006). Ngn1 and Ngn2 (Farah et al., 2000; Mizuguchi et al., 2001; Nakada et 
al., 2004; Cooper, 2013) are able to initiate neural differentiation and their sequential 
downstream targets include bHLH transcription factors NeuroD1, NeuroD2, Math2, 
Math3 and T-box proteins, Tbr1, Tbr2 (Hevner et al., 2001; Schuurmans et al., 2004; 
Englund et al., 2005). Ngn1 and Ngn2-mediated expression of Tbr1 and Tbr2 is restricted
to cortical NPCs and neurons (Schuurmans et al., 2004; Dennis et al., 2016), which 
suggests that Tbr1 is essential for neural differentiation of some cortical NPCs and that 
Tbr2 is useful as a marker for intermediate cortical NPCs committed to glutamatergic 
fate. As opposed to Ngn1 and Ngn2, which are specifically involved in neural 
differentiation in the developing dorsal telencephalon, Mash1 is implicated in basal 
ganglia development (Jiang and Nardelli, 2016). Therefore, Ngn1 and Ngn2 are shown to 
control differentiation of cortical NPCs into a glutamatergic phenotype through activation 
of their target transcription factors. On the other hand, Mash1 seems to promote neural 
differentiation into a GABAergic phenotype through activation of Dlx homeodomain 
genes. Additionally, Ngn1/2 appears to repress Mash1 activation and activities in cortical 
NPCs, but Ngn2 alone seems to initiate a neocortical glutamatergic program independent 
of Mash1 repression.
2.2.2 Axonal formation, growth and branching
During neuronal differentiation, developing neurons are highly polarized and 
characterized by the heterogeneous compartmentalization of various cellular constituents 
into discrete and physiologically significant domains, the axon and dendrite (Lewis et al., 
2013). Axonal outgrowth progresses through three stages: protrusion, engorgement, and 
consolidation (Dent et al., 2011). Protrusion is the extension of new membrane at the 
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edges of the growth cones, driven by filamentous actin (F-actin) polymerization. 
Engorgement occurs with microtubule-driven transport of membranous organelles and 
vesicles into an otherwise actin-dominated peripheral region. Consolidation results from 
changing a proximal growth cone into a cylindrical axon shaft, accompanied by the 
bidirectional movement of organelles and vesicles. As neuronal differentiation proceeds, 
axonal growth cone morphology changes dramatically as attractive and repulsive 
interactions between local microenvironmental cues and movement of underlying 
cytoplasmic axons toward appropriate synaptic targets come into play (Murray et al., 
2010). Microtubule polymerization, heterodimers of ??????????????-?????????????-tubulin) 
in a polarized manner, is required to sustain axon elongation and branching (Lewis et al., 
2013). Additionally, the disruption of microtubule-binding proteins such as APC (Shi et 
al., 2004), microtubule-associated proteins such as MAP1B (Takei et al., 2000; van de 
Willige et al., 2016) or proteins regulating microtubule reorganization are important.
Mitogen-activated protein kinase (MAPK), which regulates microtubule stability and 
axonal transport through phosphorylation of Tau, is implicated in the growth and 
branching of axons (Mandelkow et al., 2004; Sayas et al., 2015). Following elongation of 
putative axonal neurites, neurofilaments (NF) are thought to provide structural support to 
mature axons via crosslinking of cytoskeletal elements mediated by the C-terminal region 
of high molecular weight NF subunits (Lee and Shea, 2014). This stabilization supports 
overall axonal neurite elaboration. Similarly, the interaction of NFs with each other and 
with other cytoskeletal elements is regulated by a complex hierarchy of kinase activities, 
including glycogen synthase kinase 3beta (GSK), and p42-44 MAPK (Lee and Shea, 
2014). For example, BDNF, which promotes growth cone filopodial dynamics and axonal 
branching, activates MAPK (Meier et al., 2011). Moreover, p42-44 MAPK promotes NF 
axonal transport and induces NF axonal bundling (Lee and Shea, 2014).
Finally, upon reaching its target area, extensive axonal branching occurs during the 
formation of presynaptic contacts with specific postsynaptic partners. Axonal branches 
could arise either through the simple bifurcation of a growth cone tip, or through 
filopodial outgrowth from an axonal shaft to form collateral branches (Dent and Kalil, 
2001). Neuronal activity can regulate branching through modification of the actin
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cytoskeleton via RhoA activation, and local mRNA accumulates at presynaptic areas,
indicating a correlation between local translation and synaptic activity (Bakos et al., 
2015). Moreover, intracellular Ca2+ signaling has been shown to play a deterministic 
function in axon branching through activating the Ca2+/calmodulin-dependent kinases 
(CAMKs) (Lewis et al., 2013). In addition to general growth-promoting factors, the 
candidates for axon guidance, such as ephrin, semaphorin, and netrin, act in an instructive 
manner which can actively attract or repel axons. When a growth cone encounters a
guidance molecule, it extends away from chemorepellents and toward chemoattractants.
For example, netrin can induce a high intracellular calcium concentration or a high 
cAM:cGMP ratio in the DCC receptor-expressed neurons and attracts growth cone 
turning to this guidance molecule (Chilton, 2006). In in vivo studies, EphrinAs have been 
demonstrated to pattern eye-specific projections to the appropriate layers of the lateral 
geniculate nucleus (LGN) in both mice and ferrets (Huberman et al., 2005). Conversely, 
the removal of ephrinA5 in knockout mice leads to temporal axons overshooting into 
posterior regions (Averaimo et al., 2016).
2.2.3 Dendritic branching morphogenesis
For most vertebrate neuronal populations, axonal morphogenesis occurs under 
electrically silent conditions or with low levels of spontaneous activity, whereas dendritic 
development proceeds in the context of various forms of neuronal activity (Acebes and 
Ferrus, 2000). Several factors participate in ensuring correct dendritic architecture, such 
as secreted factors, cell surface receptors, cell adhesion molecules, postsynaptic density 
proteins, signaling molecules, regulators of actin cytoskeleton, the molecules that control 
ER-Golgi protein trafficking, and transcription factors (Arikkath, 2012). For example, 
BDNF has been shown to be the most critical factor regulating dendrite outgrowth and 
branching through binding to the TrkB isoforms and activation of various signal 
pathways, such as the Ras/MAPK cascade, PI3 kinase/Akt pathway, and ????-IP3-
dependent calcium release (Harward et al., 2016). During neuron development, dendrites 
initially generate long, thin, filopodial protrusions but as differentiation proceeds, these 
labile dendritic filopodia are replaced first with polymorphic protrusions and then with 
knobby actin-rich spines containing postsynaptic density (PSD-95) clusters (Niell et al., 
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2004; Chen et al., 2010). The molecular basis for cytoskeletal modifications underlying 
dendritic branching, similar to axonal branching, involves regulation of the synthesis and 
stabilization of actin and microtubule networks.
Recently, the role of unfolded protein response (UPR) signaling in dendritogenesis has 
been supported by experiments with cultured mouse hippocampal neurons. The UPR 
pathway plays a critical role in synthesis, folding and structural maturation of 
approximately one-third of all proteins produced in the cell, most of them being dedicated 
to secretion or membrane integration (Anelli and Sitia, 2008). UPR transduction involves 
the activation of ER membrane receptors that contain an ER luminal domain that senses 
the accumulation of misfolded proteins, including the inositol-requiring enzyme (Ire-1), 
the protein kinase (PKR)-like ER kinase (PERK), and the activating transcription factor 6 
(Atf6) (Godin et al., 2016). The activation of the ER stress response is a pro-survival 
mechanism which expands the ER and reduces RNA translation to limit ER protein 
loading. The UPR also clears some misfolded proteins through activation of the ER-
associated degradation (ERAD) process. However, when the UPR cannot cope with the 
overload of misfolded proteins then the cells activate a terminal UPR which finally leads 
to apoptosis (Walter and Ron, 2011). During neuronal development, dendrites acquire 
their morphology by considerable branch sprouting which comes with an increased need 
of protein production (Godin et al., 2016). Interestingly, in Caenorhabditis elegans, loss 
of ire-1 impairs dendritic morphogenesis in highly branched neurons (Wei et al., 2015).
Moreover, BDNF-induced neurite outgrowth is strongly impaired in Xbp1-/- neurons
(Hayashi et al., 2007). Since BDNF strongly enhances protein synthesis by promoting 
translation initiation in neurons, it could trigger the UPR and induce Xbp1 splicing in 
mouse hippocampal neurons. Subsequently, spliced Xbp1 is transported to the nucleus 
where it serves as a signal transducer for neurite outgrowth (Hayashi et al., 2007).
However, the molecular targets downstream of Xbp1 signaling for neurite outgrowth 
remain to be elucidated. Indeed, downregulation of Hrd-1 level, one well-known ERAD-
associated E3 ubiquitin ligase, counteracts the deleterious effect of mild ER stress on 
dendrite extension during RA-induced neuronal differentiation of P19 cells (Kawada et 
al., 2014). Altogether, these studies suggest UPR signals need to be temporally and 
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spatially fine-tuned during neuronal differentiation. Therefore, UPR levels are critical for 
neurite outgrowth which is vulnerable to both low and high signals.
2.3 Neocortex development
The CNS is made from cells that divide to form neuroepithelium, which folds into the 
fluid-filled neural tube. During the onset of neurogenesis, neuroepithelial cells divide 
asymmetrically in the VZ and SVZ of the anterior and dorsal neural tube to form radial 
glia, which produce the radially migrating newly born neurons of the neocortex (Tan and 
Shi, 2013). These neurons find their place in the six neocortical layers in an inside out 
fashion and mature to exhibit various neuronal types. GABAergic interneurons are 
generated mainly in subcortical regions and they migrate tangentially to the neocortex
(Luhmann et al., 2015). The last steps of neocortical development are axonal outgrowth
and synaptogenesis, which include making new connections and synapse pruning in an 
activity-dependent manner.
2.3.1 Neurogenesis in the developing cortex
There is a sophisticated signaling mechanism regulating the onset and maintenance of 
neurogenesis and gliogenesis (Figure 2). The onset of cortical neurogenesis and the 
transition from neuroepithelial cells to RG cells coincides with the onset of Notch 
signaling in the dorsal telencephalon as detected by the expression of the major Notch 
ligand Delta-like 1(Dll1) and the downstream transcription factors Hes1 and Hes5
(Martynoga et al., 2012). Notch is important for the instigation of RG development and 
for maintenance of neurogenic RG in an undifferentiated state. Moreover, Neuregulin 1 
(Nrg 1) is expressed in the developing cortex and signals through its receptors ErB2 and 
ErB4 to promote RG identity and to suppress the differentiation of RG into astrocytes
(Schmid et al., 2003; Sardi et al., 2006). Similar to the effect of enforced early activation 
of the Notch pathway, expression of a constitutively active form of a receptor for 
fibroblast growth factors also promotes precocious acquisition of RG cell identity (Yoon 
et al., 2004). Additionally, FGF2 maintains the proliferation of progenitors at the onset of 
neurogenesis by upregulating expression of cyclin D1 and down-regulating expression of 
the cyclin-dependent kinase inhibitor p27 (Lukaszewicz et al., 2002). Therefore, it 
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shortens the G1 phase of the cycle and decreases the proportion of neurogenic divisions.
As neurogenesis progresses, RG cells would generate neurons directly or via basal 
progenitors indirectly. Pax6, Ngn1/2 and RA promotes the direct generation of neurons 
by RG cells. Meanwhile, several transcription factors (Ap2?, Ngn2, Insm1, Tbr2) have 
been implicated in promoting the generation of basal progenitors from RG cells
(Martynoga et al., 2012).
Other transcription factors and signaling molecules also promote the self-renewal of RGs 
(Wnt, Myc) and the proliferation of basal progenitors (Foxg1, Wnt/n-Myc) (Martynoga et 
al., 2012). Another important pathway with complex inputs into the regulation of cortical 
neurogenesis is the bone morphogenic protein (BMP) pathway. Administration of BMP4
to early cortical progenitors induces neurogenesis. However, later in cortical 
development, BMPs block neurogenesis and instead promote astrocyte differentiation
(Mabie et al., 1999; Gamez et al., 2013; Scholze et al., 2014). Therefore, it is still largely 
unknown about how transcription factors interact with signaling pathways to regulate the 
generation and expansion of the different populations of neural progenitors. PDGF is 
suggested to promote neuronal fate in NPC cultures by binding to a tyrosine kinase 
receptor which in turn activates the intracellular SHP2-mitogen-activated-protein-kinase 
kinase (MEK)-ERK pathway that mediates neurogenic signals of a variety of growth 
factors (Katz et al., 2007).
Recently, compelling evidence has emerged to suggest that dynamic regulation of UPR 
signals governs the switch from direct to indirect neurogenesis (Laguesse et al., 2015).
Abundant studies demonstrated that a progressive down-regulation of UPR in cortical 
progenitors acts as a physical signal to amplify BPs and promotes indirect neurogenesis
(Paridaen and Huttner, 2014). The persistent elevation of the UPR resulting from 
defective protein translation and / or folding causes a decreased rate of indirect 
neurogenesis and subsequently a severe microcephaly. Accordingly, Grp78 mutant mice 
are also microcephalic (Mimura et al., 2008). As such, it is worth noting that only the 
Perk-?????-Atf4 branch of the UPR is strengthened in mice deficient for the Elongator 
complex (Frank et al., 2010). This implies that Atf6 and Ire1 pathways only play minor 
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roles in this pathological process. Besides its contribution to the regulation of cortical 
neurogenesis, Atf4 also controls cell cycle progression of the earliest progenitors through 
regulation of Cyclin D promoter activity and migration of the earliest born neurons by 
unknown mechanisms (Frank et al., 2010). Altogether, those studies show that neuronal 
progenitors are acutely sensitive to Atf4 dosage and that a proper level of Atf4 is required 
for efficient neurogenesis in the developing mouse brain.
Figure 2. Induction of neurogenesis and gliogenesis in the embryonic neocortex. The onset of neurogenesis 
is concomitant with the transformation of neuroepithelial stem cells (A) into radial glial (RG) stem cells 
(C). Several signaling pathways, including the Dll1/Notch/Hes1/5, Nrg/ErB, and Fgf10/Fgfr2 pathways 
have been implicated in this transformation (B), and then RG cells generate neurons directly (D) or via 
basal progenitors (E). The pathways (Pax6/Ngn2, PDGF/Ngn1, Foxc1/RA) could promote the direct 
generation of neurons by RGs. Other transcription factors (Ap2?, Ngn2, Insm1, Tbr2) have been shown to 
promote the generation of basal progenitors from RGs, whereas the Notch and FGF pathways and the 
epigenetic Ezh2 inhibit this step. Wnt, Myc et al. promote the self-renewal of RGs and the proliferation of 
basal progenitors (Foxg1, Wnt/n-Myc). The termination of neurogenesis results from the terminal 
differentiation of RGs into astrocytes (G). Multiple signaling pathways (Jack/Stat, Notch, BMP, FGF) 
synergize to elicit the neurogenic–to-gliogenic switch. The same pathways frequently operate in different 
temporal contexts to exert contrasting cellular effects. Adapted and reprinted by permission from Cold 
Spring Harbor Laboratory Press: Cold Spring Harb Perspect Biol, Martynoga, B et al., copyright 2012.
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2.3.2 Gliogenesis: timing and control mechanisms
Around E18.5 in mouse cortical development, another major developmental transition 
occurs (Fig., 2). RG progenitors stop producing neurons, and the first astrocytes appear. 
During this process, most RG become responsive to BMP, EGF, or the cytokines CNTF, 
LIF, and cardiotrophin-1 (CT-1), and glial specific genes such as GFAP and S100B begin 
to be expressed (Guillemot, 2007). The competence of RG to respond to cytokine signals 
is achieved by the action of FGF2 and EGF (Lillien and Gulacsi, 2006). Most prominent 
among the pro-astrocytic signals is the cytokine-activated Jak/Stat pathway. Although 
Jak/Stat signaling is active at a low level in progenitors during neurogenesis and may 
even be required for RG identity, at the end of this period several mechanisms cause a
sudden increase in Jak/Stat signaling. Firstly, several promoter elements in glial and Stat 
pathway genes are specifically methylated, which preclude Stat binding. This methylation
is removed at the end of neurogenesis, in part, by Notch signaling (Takizawa et al., 2001; 
Martynoga et al., 2012). Similar to the cooperation between Notch and Jak/Stat signaling, 
there is pro-astrocytic synergy between BMP and LIF which is mediated by the formation 
of a complex between Stat3, Smad1, and the coactivator p300, which together strongly 
activate the GFAP promoter (Nakashima et al., 1999). Secondly, BMP and Notch 
signaling favor gliogenesis primarily by blocking the action of proneural genes, Ngn1 
and Ngn2, which are potent antagonists of the Jak/Stat pathway (Sun et al., 2001; Scholze 
et al., 2014). Thirdly, the cytokine CT-1 starts to be expressed at high levels by 
differentiating neurons and this molecule appears to be the main activating ligand for the 
Jak/Stat pathway in vivo (Miller and Gauthier, 2007). The end results of these events is 
an increase in Stat activity, which become even more amplified because the Stat factors 
start to positively autoregulate their own transcription (Martynoga et al., 2012).
2.3.3 Neuronal subtype specification in the developing cortex
A number of layer-specific genes in the mouse neocortex have been identified (Fig., 3).
As early as E11.5, when deep layer neurons are generated, Fezf2 expression in VZ cells 
may promote the expression of Ctip2, a zinc finger transcription factor in young neurons
which, together with other genes, confers a subcortical projection neuron fate during 
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differentiation (Leone et al., 2008). At the same time, Fezf2 appears to repress Satb2
thereby repressing callosal identity. At later times during corticogenesis, when upper 
layer neurons are generated, Fezf2 expression is absent which relieves the repression of 
Satb2 (Leone et al., 2015). This, in turn, enables Satb2 to actively repress Ctip2 
expression and promote the adoption of a callosal or corticocortical neuron identity. 
Although Satb2 and Ctip2 are coexpressed by individual neurons within layer V during a 
brief time window, the coexpression quickly resolves and Ctip2 is specifically stained in 
corticospinal motoneurons (CSMN) of layer V (Arlotta et al., 2005). Finally, it is clear
that Tbr1 plays an important role in cortical development, particularly in regulating the 
differentiation of subplate neurons. Moreover, preplate gene expression during early 
corticogenenesis and layer VI neurons (corticothalamic neurons) are characterized by 
high levels of Tbr1 expression (Bulfone et al., 1999; Zhang and Jiao, 2015). Indeed, Tbr1 
knockouts exhibit a variety of axon projection defects, with corticothalamic projections 
growing only as far as the internal capsule, callosal projections mostly terminating in the 
Probst bundle not crossing the midline, and thalamocortical projections reaching the 
internal capsule, but then turning away from the cortex (Hevner et al., 2001; McKenna et 
al., 2011).
At a later embryogenic stage, when upper layer neurons are generated, Cux1 and Cux2 
are most expressed in corticocortical projection neurons of layer II-IV (Iulianella et al., 
2003). The homeodomain genes Cux1 and Cux2 are initially expressed in SVZ cells and 
in their progeny in layers II-IV. The analysis of Cux2 knockout animals has revealed that 
Cux2 promotes the exit of SVZ cells from the cell cycle (Zimmer et al., 2004).
Birthdating experiments suggest that Cux2-deficient SVZ progenitors repeat the cell 
cycle at higher frequencies than in wild-type controls, leading to an increase in the size of 
the SVZ progenitor pool (Cubelos et al., 2008). In addition, Cux1 and Cux2 are intrinsic 
and complementary regulators of dendrite branching, spine development and synapse 
formation in layer II-III neurons of cortex (Cubelos et al., 2010). As more evidence 
accumulates regarding the functional roles played by many subtype-specific genes, more 
understanding of the programs of gene expression that direct neuronal subtype 
differentiation in the neocortex should emerge (Zhang and Jiao, 2015).
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Figure 3. Gene expression patterns in the developing cerebral cortex during embryogenesis and early 
postnatal life. Summary of the expression patterns of the zinc-finger transcription factors, Fezf2 and Ctip2, 
the chromatin remodeling protein, Satb2, T-box transcription factor, Tbr1, and cut-like transcription factors 
Cux1 and Cux2 during embryonic and early postnatal development in the mouse. Dark and light red or blue 
indicate higher and lower relative levels of expression, respectively. A gene for which laminar or subtype 
expression varies by area within the neocortex is indicated by an asterisk. Abbreviations: MZ, marginal 
zone; CP, cortical plate; SP, subplate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular 
zone. Modified from (Leone et al., 2008; Martinez-Cerdeno et al., 2016).
2.3.4 Neuronal migration in the developing cortex
In the developing cortex, the migration of newborn cells is directed away from the 
proliferative zones, including the VZ and the SVZ. Radial migration is the main 
mechanism that creates the layered structure of excitatory neurons in the neocortex. 
Meanwhile, the interneurons migrate from subpallium to pallium in a tangential manner
(Marin and Rubenstein, 2003; Dennis et al., 2016).
The successful execution of migration depends on the capacity of the cell to: (i) establish 
polarity; (ii) undergo directed migration to its final destination; and (iii) terminally 
differentiate to transmit and receive information (Heng et al., 2010). Neuronal 
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polarization includes 3 stages. The first stage is disruption of neuron symmetry resulting 
from the inhibition of the RhoA-ROCK-profilin IIa signaling pathway in submembranous 
domains, leading to destabilization of actin cytoskeleton, which in turn enables initial 
neurite sprouting (Da Silva et al., 2003; Konietzny et al., 2017). Other molecular 
pathways that regulate microtubule stability in neurons also influence neuronal polarity. 
Among them, the GSK-3 pathway controls cell polarity by regulating the microtubule 
affinity of various microtubule-associated proteins (MAPs) (Barnes and Polleux, 2009).
The enlargement of the growth cone of presumptive axons followed by axon specification 
and elongation occur in stage 2 and stage 3.
When cells undergo migration, they utilize three mechanisms to arrive to their final 
positions: (i) somal translocation, whereby neuron cell body travels with pial contacting 
radial processes; (ii) locomotion, a process by which newborn neurons develop leading 
and trailing processes and migrate along RG fibers and; (iii) multipolar migration (Noctor 
et al., 2004; Subramanian et al., 2017). In addition, their migration is prefigured by 
activities of key proteins which interact with a host of other molecules to modify the actin 
and microtubule cytoskeletons (Heng et al., 2010). Central to the regulation of the actin 
cytoskeleton in neurons are several molecules, such as Arp2/3 (actin-related protein 2/3) 
complex (Goley and Welch, 2006; Pak et al., 2008), the RhoA-ROCK-LIMK-Cofilin 
pathway (Ge et al., 2006) and members of the ENA-VASP family of actin-binding 
proteins, which control the elongation of unbranched actin filaments (Goh et al., 2002; 
Kwiatkowski et al., 2007). The microtubule cytoskeleton and associated proteins are also 
important for cell migration and neuron differentiation. Microtubule filaments can be 
?????????? ????? ?????? ?????????? ?? ???????s, which heterodimeriz?? ????? ????? ????????? ??
subunits (Dutcher, 2001; van de Willige et al., 2016). Microtubule composition and its 
function are predetermined through different layers of molecular regulation: (i) gene 
expression; (ii) microtubule heterodimer composition; and (iii) post-translational 
modification. For example, studies of the genetic causes of lissencephaly and 
polymigrogyria in humans have identified tubulin-alpha1 (TUBRA1) (Keays et al., 2007)
and tubulin-beta2b (TUBB2B) (Jaglin et al., 2009) to be crucial for cortical neuron 
migration and brain development. Moreover, a host of MAPs, like Map1b, Map2 and 
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Tau, have crucial functions in regulating cortical neuronal migration and axon outgrowth
(Dehmelt and Halpain, 2004). Studies of several nonclassical MAP2s, such as 
doublecortin (Dcx), which binds to microtubules to increase their stability (Moores et al., 
2004; van de Willige et al., 2016), are shown to be important, and loss of Dcx results in 
migration deficits (Bai et al., 2003). These observations together indicate that 
spatiotemporal availability of actin and microtubule cytoskeletal proteins, as well as their 
associated proteins with downstream effectors, operate within specific steps in the 
migration of newborn projection neurons to establish polarity and correct morphology, as 
well as the appropriate mode of cell migration. Furthermore, it is known that neuronal 
migration and neurite outgrowth are correlated and can depend on similar molecular 
mechanisms. 
As the neuronal migration is implicated in corticogenesis, radial migration of newborn 
neocortical neurons has been well studied and exhibits four distinct phases. The first 
phase, after their generation at the ventricular surface, is a rapid radial migration to the 
SVZ. The second phase consists of migratory arrest for 24 hours or more, followed by a
third phase of retrograde migration toward the ventricle and a final phase of polarity 
reversal and migration toward the cortical plates. During their third phase of radial 
migration, neocortical neurons acquire a transient multipolar phenotype (Tan and Shi, 
2013).
Tangential migration is a mode of neuronal migration that is not associated with radial 
glial-guidance or direction in the CNS, although its cell mobility is similar to the steps of 
radial migration (Toma and Hanashima, 2015). Tangential migrating cells can acquire 
diverse morphological appearances with short compact processes, long elongated 
processes, or branched processes (Marin et al., 2006). Although tangential migration is 
also found throughout developing brains, it only persists in the RMS of adult brains, 
where migrating neuroblasts travel long distances through glial tunnels formed by 
astrocytes from the SVZ to the olfactory bulb. After variable subtypes of neurons arrive 
to their destined layers of neocortex, synaptic connections are established and 
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strengthened mainly in an activity-dependent fashion. The process is very complex and 
new knowledge is emerging frequently and will not be discussed further in this thesis.
2.4 Endogenous neural stem cell response to ischemic stroke
The potential of NSCs/NPCs to replace the loss of neurons and restore function after 
ischemic stroke has been shon during the last decade. Both endogenous and grafted 
NSCs/NPCs are known to have the ability to migrate to lesioned sites after brain injury 
and differentiate into new neurons (Barkho and Zhao, 2011). Several chemokines and 
growth factors have been shown to stimulate the proliferation, differentiation, and 
migration of NSCs/NPCs, and investigators have now begun to identify the critical 
downstream effectors and signaling mechanisms that regulate these processes (Table 1). 
Understanding the regulation of NSCs/NPCs properties and molecular pathways involved 
in stem cell homing into ischemic areas is vital for the development of new treatments. 
To ensure the best functional recovery, regeneration therapy may require the application 
of a combined approach that incudes cell replacement, trophic support, and neural 
protection. 
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2.4.1 The pathophysiological mechanism of ischemic stroke
Acute ischemic stroke is caused by cerebral artery occlusion through the loss or the 
reduction of cerebral blood flow, leading to an infarction of brain tissues. During the 
initial phase of the infarct, the loss of oxygen or glucose to the brain region results in 
depletion of intracellular ATP levels, causing membrane depolarization and blockage of 
protein synthesis (Barkho and Zhao, 2011). A major cause of neuronal death by oxygen 
and glucose depletion is through glutamate excitotoxicity, which can result from impaired 
ion exchange pumps, triggering the reversed extracellular release of glutamate by 
neurotransmitter transporters (Dirnagl et al., 1999; Kim et al., 2017). High concentrations 
of extracellular glutamate act on receptors on post-synaptic neurons and can lead to 
calcium influx, failure of mitochondria, energy depletion, and eventually neuronal death 
through apoptosis (Trendelenburg, 2014) . The area where the cells lose metabolic 
activities and quickly die in the absence of reperfusion is defined as the ischemic core. In 
most cases, the ischemic core is considered “out of reach” for neuroprotective treatments
(Saver et al., 2010). The surrounding area, called the penumbra, is supplied partly by 
collateral blood vessels. Since it experiences a milder loss of cerebral blood flow (CBF, a 
60-80% reduction), cells of the penumbra are initially able to prevent complete loss of 
ATP (Yan et al., 2015). However, some of the damage done to the brain following stroke 
comes from delayed effects, including release of nitric oxide, oxygen free radicals, and 
depolarizing waves of spreading depression originating from the ischemic core. Cells of 
the penumbra are exposed to these conditions under which they are unable to cope with 
increasingly harmful insults and the penumbra eventually converts to an irreversibly 
damaged ischemic core.
Besides the harmful effects on neurons, ischemia can damage the integrity of the 
neurovascular network via release of matrix metalloproteinases (MMPs) and other 
proteases secreted by endothelial cells that compromise the protective blood brain barrier 
(BBB) (Lo et al., 2003). The loss of neurovascular structural integrity results in a 
breakdown of the tight junctions between astrocytes and endothelial cells, which 
contributes to cerebral edema. The events described above are important factors to 
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consider not only when treating stroke patients, but also critical for cell-based therapies 
using endogenous or transplanted stem cells.
2.4.2 Stroke-induced neurogenesis
Using an embolic middle cerebral artery occlusion (MCAO) model in adult rodents, 
many studies have shown that within the first week after focal ischemic insult there is a 
major increase in NSC proliferation within the SVZ (Barkho and Zhao, 2011). Increased 
NSC proliferation has also been seen in both the hippocampus and the SVZ after trauma, 
seizures, and global ischemia during the first week after injury, and the rates of 
proliferation return to normal after several weeks (Parent et al., 2002; Kernie and Parent, 
2010). It is well known that FGF-2 appears to play a critical role in regulating injury-
induced NSC proliferation and this effect is attenuated in FGF-2 knockout mice in vivo
(Addington et al., 2015). Much like FGF, SVZ proliferation after stroke was found to
increase in vascular endothelial growth factor (VEGF)-overexpressing transgenic mice,
suggesting VEGF may also contribute to NSC proliferation within the SVZ after injury
(Thau-Zuchman et al., 2010). At two weeks after the injury, newly generated SVZ-
derived cells re-route from the SVZ and RMS into the damaged area (up to 2mm 
distance), where some of these cells are found to express differentiated cell markers at 
later time points (Kokaia and Lindvall, 2003; Lindvall et al., 2004). Ultimately, the 
increased number of migrating neuroblasts found in the SVZ or dentate granule layer, the 
majority of which are neuroblasts predisposed to migrate to damaged regions, will not 
survive (Takasawa et al., 2002; Tonchev et al., 2005). Therefore, injury-induced 
neurogenesis is suspected of being regulated by extrinsic factors secreted from reactive 
cells within the infarct regions. However, the number of neurons generated from 
endogenous NPCs is extremely low (~0.2% of the striatal cells lost), and the survival of 
these new neurons in the lesioned area is minimal (Arvidsson et al., 2002). A major 
problem with stem cell migration to the injured stroke area is subsequent apoptosis of the 
newly migrated NSC. Recently, an approach to prevent this is characterized by the use of 
regulatory factors that have been implicated in neurogenesis, such as GDNF, BDNF, 
VEGF, granulocyte colony-stimulating factor (G-CSF), FGF–2, insulin-like growth 
factor–1, bone morphogenetic protein–7, epidermal growth factor, and transforming 
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growth factor–? (Azad et al., 2016) in order to protect the NSCs/NPCs. Alternative 
strategies to increase NPC proliferation include using anti-inflammatory drugs, 
noncoding RNAs, and hormones such as erythropoietin and growth hormone (Wang et 
al., 2004; Hoehn et al., 2005; Schouten et al., 2012). A complementary approach strives 
to limit NPC death through administration of G-CSF and insulin-like growth factor-1 to 
alter key survival pathways (Lee et al., 2006). Inhibition of P53 and the use of 
cyclosporine have also been studied as strategies to extend NPC survival (Luo et al., 
2009; Erlandsson et al., 2011).
2.4.3 The migration of neural progenitor cells after brain injury
In recent years, interest in understanding the physiological and pathological processes of 
progenitor cell migration has increased, due largely to the discovery of neural progenitor 
cell migration in the adult brain under normal or injured conditions. Above, we have 
reviewed the mechanisms of neuronal migration in developing brains. In adult brains, 
migrating neuroblasts travel long distances through a glial tunnel formed by astrocytes 
from the SVZ to the olfactory bulb. Upon arrival at the olfactory bulb, neuroblasts switch 
to radial migration to reach their destination. Interestingly, under pathological conditions, 
these cells also have the capacity to adapt similar migration patterns in response to 
changes in their surrounding environment (Goings et al., 2004).
Upon neuroinflammatory injury, which occurs in stroke or trauma, chemokines are 
produced by reactive cells, such as astrocytes, and endothelial cells express higher levels 
of chemokines, like stromal cell-derived factor 1(SDF-???? ???? ?????? ?????? ??????-
induced chemokines are reported to attract inflammatory cells and cause cell death in 
diseased or injured regions; however, chemokines can also direct neuronal progenitor 
cells (NPCs) to re-route towards a stroke-induced injury (Wiltrout et al., 2007).
Chemokine-induced cell migration requires the remolding of the extracellular matrix 
(ECM). The chemotaxic functions of SDF-1 (Thored et al., 2006) and VEGF (Zhang et 
al., 2002) are known to be mediated by the activation of MMPs, which are a family of 
enzymes responsible for degrading the components of the ECM. For example, after 
ischemic injury, neuroblasts are in close proximity to the endothelial cells of the 
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vasculature and secrete MMPs to degrade laminin, one of the basement membrane 
proteins of the ECM, to mediate cell migration (Lee et al., 2006; Wang et al., 2006).
Furthermore, it has been shown that MMPs, with their ability to disrupt the interaction 
between integrins expressed on the cell surface and the ECM, can activate cell surface 
molecules such as receptor tyrosine kinases (RTKs), G-protein coupled receptors 
(GPCRs), and membrane tetraspanin family of proteins (Barkho and Zhao, 2011). When 
these receptors are directly or indirectly activated they transduce signals through several 
pathways, including focal adhesion kinase, the Src family kinase Fyn, MAPK, SH2-SH3 
adaptors, Rho-family GTPases, and phospholipid mediators (Barkho and Zhao, 2011).
The activation of these signaling cascades ultimately results in a number of changes in 
plasma membrane localization, microtubule assembly, and interaction with the 
cytoskeleton, which are also implicated in NPC differentiation. Therefore, it has been 
suggested that the stroke-induced NPC migration and neuronal differentiation, including 
neurite outgrowth, may be correlated and depend on particular molecular mechanisms
that can modulate both activities. 
Additionally, stroke increases the expression of BDNF and other growth factor or NTFs
in adult rat cortex or neostriatum near the rostral SVZ or RMS (Bath and Lee, 2010). In 
some instances, increased expression is sustained for up to 14 days, similar to the 
temporal pattern of ischemia-induced neurogenesis and neuroblast migration. However, 
the functions of these endogenous growth factors have been mostly implicated in NSC
proliferation, neuronal differentiation, and survival after brain injuries. 
2.4.4 Therapeutic application of endogenous NPCs
Since short-term pharmaceutical treatments for brain injury have had limited success, 
stem cell-based therapies are now the subject of intense investigation. Endogenous adult 
NSCs residing in the neurogenic niche may be beneficial for brain repair as a result of 
their ability to support neurogenesis and gliogenesis during adulthood. However, the 
microenvironment surrounding the NSCs changes drastically after brain injuries due to 
the reactivity of neighboring cells, such as astrocytes, endothelial cells, and microglia
(Barkho and Zhao, 2011). The release of cytokines from these cells changes the 
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microenvironment and therefore the niche for endogenous adult NSCs. As mentioned 
above, adult NSCs in the SVZ initially experience a massive proliferative response within 
the first week of ischemic stroke in response to an increase of cytokines, like TNF-?
(Katakowski et al., 2007; Yan et al., 2015). However, the majority of these cells either 
fail to survive or to differentiate into glial cells when stimulated by the high 
concentrations of inflammatory cytokines secreted by neighboring cells.
Even though endogenous adult NPCs have the capacity to replace lost neurons in animal 
models of cerebral ischemia, the potential for functional recovery in humans remains 
uncertain. In the rodent stroke model, the efficiency of endogenous adult NPCs at 
generating new neurons that will survive and repair the damaged area is extremely low
(Kokaia and Lindvall, 2003). Therefore, one current strategy focuses on promoting NPC 
recruitment to the injured area using chemokines and growth factors within the lesioned 
area. These factors can attract large numbers of endogenous NPCs to the injured area, and 
some of these cells may participate in brain regeneration. Growth factors, such as BDNF
(Benraiss et al., 2001; Vilar and Mira, 2016) and VEGF (Jin et al., 2002; Ottoboni et al., 
2017), have been used with some success; however, functional recovery was limited. 
Other peptides that provide neuroprotection and recovery in ischemic stroke preclinical 
models include CART (Luo et al., 2013) and sonic hedgehog agonists (Jin et al., 2015; 
Jin et al., 2017) . More recently, it has been suggested that a combination of these factors 
might have a synergic effect to promote endogenous stem cell therapy and improve brain 
function. For example, simultaneous promotion of neurogenesis and angiogenesis could 
result in a better therapeutic outcome. However, increased angiogenesis can also lead to 
greater permeability of the BBB, causing more cerebral edema after the acute stage of a
stroke insult (Zhang et al., 2000; Zhang et al., 2017). Thus, it is also important to define 
an optimal time period and specific dosage for any growth factor or cytokine treatment.
Therefore, modulating endogenous NSC/NPCs for brain repair is a critical issue facing 
stem cell therapy. Acquiring this knowledge will require more research into the basic 
biology of NSC/NPCs and their interaction with the surrounding microenvironment after 
brain injury.
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2.5 Neurotrophic factors and ischemic brain injury
2.5.1 Classification of neurotrophic factors
NTFs are secreted proteins that produce their trophic effects by activating specific 
receptors on the neuronal cell surface. Trophic factors in the CNS are grouped into 
families based on structural homology, receptors, and common signal transduction 
pathways (Fig., 4). Four major classes comprise the family of NTFs: (i) neurotrophins 
include NGF, BDNF, neurotrophin-3 (NT-3) and -4 (NT-4); (ii) the GDNF family of 
ligands (GFLs) including neurturin (NRTN), artemin (ARTN) and persephin (PSPN);
(iii) neurotrophic cytokines (neurokines) with CNTF, CT-1, CT-2, IL-6; and (iv) the 
newest family consisting of cerebral dopamine neurotrophic factor (CDNF) and 
mesencephalic astrocyte-derived neurotrophic factor (MANF) (Lindholm and Saarma, 
2010).
Figure 4. Classification of neurotrophic factors. Neurotrophic factors are classified into four groups 
depending on the structure and function. Neurotrophins function via binding to TrkB or P75NTR receptor in 
a variety of brain functions. Sortilin is newy identified proneurotrophin receptor mainly expressed in TGN 
and is shown to be involved in the processing for mature neurotrophins. The TGF-?????????????????????????
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?????????????????????????????????????????????????????????-1-RET to function and function as a dimer. 
Neuroprotective cytokines consist of CNTF, LIF, and IL-6. Homodimers of these molecules bind to 
CNTFR, LIFR, or gp130, and receptor dimer formation is important for signal transduction. The 
mechanism of CDNF and MANF cytoprotective action is still largely unclear, and their ability to bind 
transmembrane receptors has not been demonstrated. Although MAND and CDNF can be secreted from 
cells, they are largely retained intracellularly in the ER for protein homeostasis. Modified from (Lindahl et 
al., 2017; Sato, 2017).
The actions of neurotrophins are mediated through the Trk family of RTKs (TrkA, TrkB,
and TrkC) and p75 neurotrophin receptor (p75NTR), all of which are transmembrance 
receptors (Huang and Reichardt, 2001). Upon ligand binding, Trk receptors can activate 
such intracellular pathways as MAPK-pathway, PI3K-pathway and PLC-?? ?????????
meanwhile p75 activates NF-kB and JAK-pathway. The p75NTR has high affinity for 
pro-neurotrophin, whereas mature neurotrophins have greater affinities for TrkB. Indeed, 
p75NTR, a death domain receptor, associated with Trk co-receptor enhances or 
suppresses neurotrophin-mediated cell survival (Bachis et al., 2012).
Similar to the neurotrophin family, the GDNF family of ligands are synthesized as 
precursor proteins that are cleaved into mature proteins. The members of the GDNF 
family are distant members of the TGF-????????????? with low sequence similarity, but 
with identical spacing of seven conserved cysteine residues, and also belonging to 
cysteine knot proteins (Airaksinen and Saarma, 2002). The common signaling receptor 
for all GDNF family ligands is the RET (REarrangement during transformation) tyrosine 
kinase receptor (Durbec et al., 1996; Trupp et al., 1997). All GDNF family ligands first 
bind to their corresponding GDNF family receptor-?? ??????? ???????s forming a high 
affinity complex. GDNF, NRTN, ARTN and PSPN ???????????????????????????????????
?????? ??????????? ???????????? (Airaksinen and Saarma, 2002)?? ?????????-receptor 
has been shown to exist as bound to the plasma membrane by a 
glycosylphosphatidylinositol anchor, but it has also been shown to be biologically active 
in a soluble form (Paratcha et al., 2001). Homodimeric GDNF-??????? ???????????-
receptor complexes induce dimerization of two RET molecules, leading to 
autophosphorylation of tyrosine residues in the intracellular domains of RET proteins.
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2.5.2 The role of BDNF and GDNF in the models of ischemic brain injury
Numerous studies have reported that exogenous BDNF treatment after acute ischemic 
insult reduces infarct volume and significantly restores behavior function (Schabitz et al., 
1997; Yamashita et al., 1997; Schabitz et al., 2000). Following subcortical ischemic 
stroke in adult rats, increases in oligodendrocyte differentiation and myelin formation are 
observed at 7 and 28 days after single-dose BDNF injected at 24h after injury (Ramos-
Cejudo et al., 2015). In photothrombotic stroke model, daily intravenous injections of 
BDNF for five days improves sensorimotor outcomes as assessed by rotarod, balance 
beam. Implantation of BDNF-transfected fibroblasts into the somatosensory cortex after 
stroke induced the upregulation of Trk?? ?????????? ??? ????????? ???????? in the penumbra, 
which increased neuronal survival in the cortex (Ferrer et al., 2001). GDNF has also been 
shown to have neuroprotective effects following ischemic brain injury when introduced 
to the brain by viral vectors or GDNF-expressing cells (Duarte et al., 2012). Similar to 
VEGF, there have been no clinical trials using exogenous BDNF or GDNF astherapeutic 
agents. The lack of clinical trials may be secondary to difficulty of extracting or 
producing appropriate amounts of these neurotrophic factors for use in humans
(Nagahara and Tuszynski, 2011), as well as questioning of growth factor proteins-
induced tumore formation or side effects (Kawai et al., 2000; d'Anglemont de Tassigny et 
al., 2015).
2.5.3 The role of BDNF for endogenous NPCs in the stroke cortex
Interestingly, BDNF treatment has also been shown to increase neurogenesis in dentate 
gyrus as well as migration of SVZ progenitor cells to striatum of the injured hemisphere. 
Previous studies have demonstrated p75NTR expression defines a population of cells in 
the SVZ that persists into adulthood and is able to respond to stimulation by 
neurotrophins (Young et al., 2007). It has also been suggested that BDNF induces
neurogenesis via p75NTR activation, but also affects dendritic development of SVZ-
derived neurons via its high affinity receptor TrkB (Bath and Lee, 2010). While there is 
evidence in ischemic models for BDNF upregulation within the injury penumbra, the 
BDNF-mediated effects in the stroke brain are controversial (Galvao et al., 2008). These 
discrepancies, along with data showing that BDNF modulates other neurogenesis-related 
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factors such as VEGF, indicate that the effects of BDNF on neurogenesis after stroke 
may be indirect (Talwar and Srivastava, 2014). Indeed, a recent study has shown that 
BDNF promotes differentiation and maturation of adult-born neurons indirectly by 
enhancing the release of GABA from interneurons (Waterhouse et al., 2012). However, 
several reports support the idea of a direct effect of BDNF on SVZ migration in stroke 
animals. Systemically applied BDNF has been shown to enhance recruitment of NPCs 
into ipsilateral striatum after stroke (Schabitz et al., 2007). In addition, Sofia et al. and 
others have demonstrated that neuroblasts in the damaged striatum express p75NTR and 
migrate along the astroglial scaffold in response to vasculature-expressed BDNF (Grade 
et al., 2013). It is suggested that BDNF plays a pivotal role in the switch from the 
stationary to the migratory phase of neuroblasts by promoting the initiation of migration 
of cells navigating into the damaged striatum. Nevertheless, TrkB-expressing astrocytes 
in the ischemic area envelop the vessels and trap BDNF to modulate its availability for
neuroblast migration, which may be one reason why injury-induced migration of 
neuroblasts to the striatum is much slower than constitutive migration in the RMS.
Although evidence supports that increasing BDNF has the potential to facilitate the 
migration of SVZ cells in the stroke brain, it is unclear if this improvement of cell 
migration is mediated through an action in the SVZ or the target lesioned sites.
2.6 The MANF family of neurotrophic factors
2.6.1 Structure and expression of MANF
MANF and CDNF proteins are produced from homologous genes found in the genomes 
of vertebrates, such as humans, rodents, and zebrafish (Danio rerio). The genomes of 
invertebrates, fruit fly and nematode, have a single orthologue that is slightly more 
homologous to human MANF than CDNF genes (Petrova et al., 2003; Lindholm et al., 
2007). Analysis of their primary amino-acid sequence predicted the presence of an
amino-terminal (N-terminal) signal peptide, four possible intramolecular cysteine bridges 
and a C terminal ER retention signal that directs them to the ER, which when cleaved can 
result in a mature protein being secreted (Mizobuchi et al., 2007). MANF was shown to 
be an intracellular protein co-localizing with markers of the ER and can be secreted in 
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response to ER stress (Apostolou et al., 2008; Henderson et al., 2013). Crystallographic
studies of the structure of human MANF and CDNF revealed that they have two domains
(Parkash et al., 2009) (Fig., 5). The folding of MANF and CDNF into two distinct 
domains linked with a flexible loop, and the conformation of the C-terminal domain was 
verified with NMR studies of full-length proteins (Hellman et al., 2011; Latge et al., 
2015). The N-terminal domain of MANF and CDNF has structural homology to saposin-
like proteins, a family of proteins with diverse functions but a shared ability to interact 
with lipid or membranes (Bruhn, 2005; Parkash et al., 2009). The C-terminal domain of 
MANF was shown to be similar to the SAP-like domain proteins (SAF-A/B, Acinus, and 
PIAS) including Ku 70, a protein required for the non-homologous end joining for DNA 
repair, but also shown to have antiapoptotic properties (Hellman et al., 2011). Moreover, 
the last four amino acids of MANF are similar and recognized by KDEL-receptors that 
facilitate the ER retention of proteins from Golgi to ER (Raykhel et al., 2007).
Accordingly, the RTDL motif of MANF has been shown to be important for retaining 
MANF in the ER, as its deletion or mutation increases the secretion of MANF and causes 
mislocalization from the ER. Deletion of the corresponding KDEL motif of CDNF 
similarly increases the secretion of overexpressed CDNF (Glembotski et al., 2012; 
Henderson et al., 2013; Henderson et al., 2014).
Figure 5. (A) Schematic images showing the position of the signal sequence (“Pre”), conserved cysteine 
residues (yellow vertical bars), disulfide bridges (black connecting) and C-terminal KDEL receptor-binding 
motif (black bars) in the primary structure of human CDNF and MANF orthologues from human, 
Drosophila melanogaster and Caenorhabditis elegans. (B) NMR solution structure of human MANF 
consisting of an N-terminal saposin-like domain (residues 1-95) and a C-terminal SAP-like domain 
(residues 96-158). The hinge region (residues 96-103), CXXC motif and ER retention signal are indicated. 
N, amino-terminus; C, carboxy-terminus. (A), modified from (Lindholm and Saarma, 2010) (B), adapted 
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and reprinted by permission from The American Society for Biochemistry and Molecular Biology: Journal 
of Biological Chemistry, Hellman et al., copyright 2011.
2.6.2 Regulation of ER stress by MANF
A number of cellular insults including pharmacological perturbation, reduction in ER 
calcium stores, viral infections, altered protein glycosylation, and increased or 
unbalanced protein expression can disrupt protein folding and cause accumulation and 
aggregation of unfolded proteins in the ER lumen. This causes ER stress and if 
prolonged, leads to ER stress -induced apoptosis. MANF has been shown to be 
upregulated in cultured cells in response to ER stress-inducing neurotoxins (Holtz and 
O'Malley, 2003) and other inducers of the UPR, like tunicamycin, an N-glycosylation 
inhibitor, and thapsigargin, a sarco/endoplasmic reticulum Ca2+ ATPase inhibitor (Lee et 
al., 2003; Apostolou et al., 2008; Liu et al., 2016). Also, stress insults or pathological 
conditions involved in acute or chronic ER stress have been shown to upregulate Manf 
expression in vivo. The former includes a tunicamycin-induced UPR in the developing 
mouse brain (Wang et al., 2015), a mouse model of experimental acute myocardial 
infarction (Harpster et al., 2006; Tadimalla et al., 2008), and a transient focal cerebral 
ischemia model (Airavaara et al., 2009). The models of chronic ER stress exhibiting 
Manf upregulation include a pancreatic beta-cell-derived cell line expressing a 
misfolding-prone version of the proinsulin gene (Mizobuchi et al., 2007) and mouse 
models of genetic skeletal diseases based on the ER retention of mutant forms of 
matrilin-3 (MATN3) (Hartley et al., 2013). The presence of an XBP1-binding ER stress 
response element in Manf´s promoter, and dependence of Manf induction on XBP1 or 
ATF6, support the observation that Manf upregulation is a genuine part of the UPR.
While tunicamycin treatment upregulates the UPR, it does not cause MANF secretion, 
showing that MANF secretion is not a general response to ER stress (Oslowski and 
Urano, 2011). The secretion of MANF in response to calcium depletion in the ER caused
by thapsigargin is robust. Moreover, MANF’s secretion has been shown to be related to
two different mechanisms of MANF´s retention in the ER: one determined by the 
interaction of MANF with GRP78 and the other dependent on the relatively weak C-
terminal ER retention signal (Henderson et al., 2013).
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2.6.3 Characterization of MANF in genetic model systems
MANF in vivo biology was studied at first in Drosophila melanogaster. An invertebrate 
NTF in Drosophila, DmMANF, was identified as a Drosophila ortholog of human 
MANF. DmMANF was expressed in glial cells and was required for the development of 
the Drosophila nervous system (Palgi et al., 2009). Genetic ablation of DmMANF 
produced lethality at the larval stage. Maternal and zygotic DmMANF null mutants 
showed a complete loss of dopaminergic neurites and a drastic reduction of dopamine 
levels. These events were followed by degeneration of axonal bundles in the embryonic
CNS with subsequent cell death. Genetic rescue experiments showed the restricted 
expression of human MANF (not expressed in muscles, body fat or gastric caeca) can 
compensate for the loss of DmMANF. Human CDNF could compensate for the loss of 
DmMANF, but much less potently than MANF. These developmental studies with 
DmMANF were complemented with gene expression analysis of two differing 
DmMANF genetic deletion mutants using DNA microarrays (Palgi et al., 2012).
DmMANF deletion led to expression changes in about 40% of known ER / UPR genes 
supporting a role of MANF in this cellular stress response pathway. In line with this, 
?????????? ???????????????? ??? ?????, indicating activated UPR in the DmManf?????
embryos, was demonstrated by Western blotting (Palgi et al., 2012). Moreover, gene 
expression profiling of DmManf mutants revealed altered expression of several genes 
involved in dopamine uptake, synthesis, and transport, as well as mitochondrial and 
nuclear genes involved in mitochondrial respiration known to be associated with PD.
Expression of genes involved in ATP-binding nucleic acid metabolism, transmembrane 
transport, exocytosis and endosomal recycling as well as DNA replication were
downregulated. Some upregulated genes were clusters of immune and defense response 
genes and genes associated with lipid metabolism, oxidoreductases and cell death.
Interestingly, when DmMANF was overexpressed in a different Drosophila line, an 
increase in the expression of genes involved in oxidation reduction is observed, hinting at 
the possibility that DmMANF may be involved in protecting dopaminergic neurons from 
oxidative stress (Palgi et al., 2012).
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In zebrafish MANF is similarly widely expressed. Although knockdown of MANF with 
splicing-blocking antisense oligonucleotides did not result in an apparent phenotype, it 
decreased brain dopamine levels by about 50% and the number of tyrosine hydroxylase 
(TH)- and dopamine transporter-expressing cells in certain brain areas (Chen et al., 
2012). While studies on the role of MANF in mammalian nervous system development 
have not been reported yet, the analysis of Manf -/- mice has provided a definitive link of 
MANF to the UPR. With MANF deficiency, adult mice developed type I diabetics due to 
progressive decreased insulin production and ?-cell death. The phenotype of full-
knockout animals was similar to the conditional pancreas-specific deletion of MANF
(Lindahl et al., 2014). The insulin deficiency results from increased death and decreased 
?????????????? ??? ??????????? ?-cells. This correlates with upregulation of UPR genes 
(CHOP, GRP78, ATF4 and ATF6), enhanced Xbp1 splicing ???? ?????????? ??????
phosphorylation (Lindahl et al., 2014). Notably, upregulation of some UPR markers 
??????????-cell loss, indicating that chronic UPR is a cause, rather than a consequence, of 
?-cell death.
In the mouse model of spinocerebellar ataxia 17 (SCA17), the accumulation of a mutant 
TATA box binding protein (TBP) leads to cerebellar Purkinje cell degeneration
accompanied by decreased expression of MANF in the cerebellum. Overexpression of 
MANF ameliorates mutant TBP-mediated Purkinje cell degeneration possibly via protein 
kinase C (PKC)-dependent signaling (Yang et al., 2014a).
Endogenous MANF has recently been reported to play neuroprotective and regenerative 
roles in the fly and mouse models of retinal injury (Neves et al., 2016). Light-induced 
damage to mouse retina resulted in the accumulation of MANF-expressing cells also 
displaying characteristics of innate immune cells, such as microglia and leukocytes of 
myeloid origin. Upon treatment with recombinant MANF or transplantation of MANF-
expressing fibroblasts, the CD11b-positive cells (a marker of microglia) recruited by the 
damage started to express markers of alternative immune activation (Ym1 and Arginase-
1). Remarkably, MANF also had this effect on isolated bone marrow-derived 
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macrophages. Moreover, light-induced damage to retina was more severe in mice 
carrying a single functional MANF allele. The protective effect of recombinant MANF 
on photoreceptors was also seen in two genetic models of retinal degeneration. The 
MANF-modulated innate immune cells promoting survival of photoreceptors was 
counteracted by diphtheria-toxin-mediated depletion of CD11b-positive cells or genetic 
ablation of Cx3Cr1, a chemokine receptor expressed by monocytes/macrophages and 
resident microglia. 
2.6.4 Therapeutic effects of MANF in various lesion models
Studies on the therapeutic efficacy of MANF in animal models of acute or progressive 
diseases have mostly concentrated on Parkinson’s disease (PD), ischemic injury, and 
degenerative diseases.
There are limited data available concerning MANF’s therapeutic properties in animal 
models of PD. Pretreatment with intrastriatal injection of recombinant human MANF 
(rhMANF) was shown to rescue TH-positive neurons in the substantial nigra pars 
compacta (SNpc) from 6-OHDA-induced cell death (Voutilainen et al., 2009). Moreover, 
injection of rhMANF several weeks after 6-OHDA administration reversed the toxin-
induced behavioral changes seen using amphetamine-induced rotations. However, there 
was no statistically significant reduction of loss of dopamine neurons and degeneration of 
striatal dopaminergic fibers. Although adeno-associated virus (AAV)-mediated 
intrastriatal delivery of MANF has recently been reported to protect the SNpc dopamine 
neurons and to increase the density of striatal TH-positive fibers (Hao et al., 2017), these 
data were contradicted by observations that intrastriatal lentiviral delivery of rhMANF 
had no beneficial histological or behavior effects (Cordero-Llana et al., 2015). Similarly, 
chronic infusion of rhMANF had no effect on 6-OHDA-induced motor deficits or on 
degeneration of SNpc TH-positive neurons and their striatal afferents. Despite some 
mechanistic insights into the function of MANF, its mode of therapeutic action in PD 
models is still obscure. 
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MANF has also been shown to protect both cardiac myocytes and neurons from death 
caused by a period of ischemia followed by reperfusion (table 2). For cardiac myocytes, it 
has been shown that both overexpressed and extracellularly applied mouse MANF 
protect cultured cardiac myocytes from simulated ischemia. In a follow-up study, 
intravenous infusion of MANF in vivo also protected mouse cardiac muscle from 
transient coronary artery occlusion (Glembotski et al., 2012). Airavaara and colleagues 
studied the possible protective effect of rhMANF using a cortical stroke model of distal 
middle cerebral artery occlusion (dMCAO) (Airavaara et al., 2009). Intracortical 
injection of rhMANF just before dMCAO limited the size of the infarction in a dose-
dependent manner. MANF protected brain tissue by decreasing the number of apoptotic 
cells, but had no effect on cerebral blood flow (Airavaara et al., 2009). In addition, the 
administration of MANF exerted a local CNS therapeutic effect, rather than changes in 
body temperature, blood pressure, or blood gases values. In a subsequent study, AAV-
mediated overexpression of MANF had neuroprotective effects on cortical neurons 
against ischemic injury. Compared to the control group with AAV-GFP, AAV-MANF 
treated rats had significantly smaller infarction volumes, indicating that overexpressed 
MANF can also counteract ischemic-induced cell injury (Airavaara et al., 2010).
Similarly, intracerebroventricular (i.c.v.) administration of MANF two hours after the 
MCAO also reduced infarct size and decreased apoptosis, assessed by the number of 
positive cells after terminal deoxynucleotidyl transferase dUPT nick end labeling 
(TUNEL) and levels of cleaved caspase-3 (Yang et al., 2014b). Much like the models of 
myocardial ischemia, the UPR is also known to influence preservation of cell viability in 
models of cerebral ischemia-reperfusion, but the mechanism of MANF´s protection is 
still unknown.
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Table 2. Therapeutic application of MANF in animal models of ischemic injury
Year Model Treatment Outcome Reference
2009 Transient distal MCAo Intracortical injection 
of rhMANF 20 min 
before ischemia
Smaller infarct size (+)   
Enhanced behavior recovery (+) 
reduced apoptosis in the cortex
(Airavaara et 
al., 2009)
2010 Transient distal MCAo Intracortical AAV7-
hMANF injection 1 
week before ischemia   
Smaller infarct size (+)     
Enhanced behavior recovery (+)
(Airavaara et 
al., 2010; 
Glembotski 
et al., 2012)
2012 Myocardial 
ischemia/reperfusion
Intravenous rhMANF  
24h before injury
Smaller infarct size (+) (Airavaara et 
al., 2009; 
Glembotski 
et al., 2012)
2014 Transient proximal 
MCAo
Intracerebroventricul
ar rhMANF, 2h after 
ischemia/reperfusion
Smaller infarct size (+)     
Enhanced behavior recovery (+) 
Reduced apoptosis in the cortex
(Yang et al., 
2014b; 
Matlik et al., 
2015)
2015 Transient distal MCAo Intracortical injection 
of MANF-????? 20
min before ischemia
Smaller infarct size (+)     (Airavaara et 
al., 2010; 
Matlik et al., 
2015)
A significant loss of pancreatic beta cells in Manf -/- mice raised the question of whether 
therapeutic application of MANF could rescue beta cells. Indeed, AAV-mediated 
overexpression of hMANF protected pancreatic beta cells from death induced by 
streptozotocin (a DNA-damaging alkylating agent taken up by pancreatic beta cells). 
Even though the effects of AAV-MANF treatment on blood glucose and insulin levels 
were not statistically significant, it did cause an increase in the number of proliferating 
beta cells, suggesting that MANF has a regenerative effect and therefore might be a
potential drug candidate for type I diabetes (Lindahl et al., 2014).
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The neuroprotective role of endogenous MANF in the fly and mouse models of retinal 
injury were discussed above (see section 2.6.2). In addition, MANF delivery increased
integration of transplanted photoreceptors into degenerating retinas and restored visual 
function in the mammalian retina (Neves et al., 2016). Although this study supports the
observation that MANF, by modulating the inflammatory microenvironment, improves 
the integration of photoreceptors in degenerating retinas, it does not exclude the 
possibility that MANF may act directly on refractory photoreceptors to improve their 
integration capacities. In summary, currently available studies indicate that treatment 
based on MANF, either as a therapeutic agent or a factor for improving the efficiency of
cell-based therapies, could have a protective and regenerative potential for a number of 
different diseases.
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3 AIMS OF THE STUDY
The overall aim of this work was to investigate the effects of neurotrophic factors on the 
properties of NSCs/NPCs in homeostatic or pathological conditions, and to use this 
knowledge for developing more effective stem-cell therapies in injured brains.
Specific aims were:
? To determine the role of MANF in neuronal differentiation and migration in the 
developing mouse cerebral cortex.
? To determine the mechanisms involved with MANF regulation of neurite outgrowth 
when NSCs start to differentiate.
? To investigate and compare the effects of GDNF and MANF treatment on adult 
NSCs/NPCs after focal cortical stroke.
? To investigate whether BDNF has trophic activity in the SVZ to enhance the 
migration of SVZ cells toward the lesioned area.
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4 MATERIALS AND METHODS
Molecular biology experiments Original articles My contribution to the 
experiments
MANF full-ko lines and genotyping I/II
Nesting-Cre mouse lines and 
genotyping
Lindahl. et al. 2014 
Construction of plasmid DNA vectors II +
Quantitative reverse transcription 
polymerase chain reaction (qPCR)
I +
Cell culture experiments
Production of lentiviral vectors II
Production of AAV vectors III
Culturing primary neurons II +
Neural stem cell culture I/II +
Oxygen-glucose deprivation test II +
Subventricular zone explant culture and 
migration assay
II +
Flow cytometry II +
Immunological methods in vitro
Immunocytochemistry I/II +
Enzyme-linked immunosorbent assay II +
Western blot analysis I/II +
HPG labeling I
PI labeling II
Immunological methods in vivo
Immunohistochemical staining I/II/III +
Immunofluorescent staining I/II +
Western blot analysis I +
Animal models
Stereotaxic intracerebral injections II/III +
Rat MCAo model of ischemic injury II/III +
BrdU labelling I/II +
Minipump implantations II +
Mouse MCAo model of ischemic injury unpublished data +
Behavior tests (a modified Bederson´s 
neurological test, elevated body swing 
test, cylinder test and Rotarod test)
III/unpublished 
data
+
TTC staining III/unpublished 
data
+
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Imaging
Fluorescent microscopy I/II +
Quantitative image analysis I/II/III +
4.1 Published methods
All methods used in my studies are listed in the above table. The more detailed 
information on materials and methods can be found in the original articles (I, II and III).
4.2 Unpublished methods
4.2.1 The mouse model of permanent middle cerebral artery occlusion (pMCAo)
Adult Manf flox/flox(fl/fl) (WT) and NesinCre/+:: Manf flox/flox(fl/fl) (MANF-cKO) (8-10 weeks)
(Lindahl et al., 2014) were anesthetized with chloral hydrate (0.4g/kg, intraperitoneally)
(Sarabi et al., 2003). Chloral hydrate has been a popular hypnotic anesthetic agent used in 
laboratory rodents. Its advantages include: 1) rapid onset of action; 2) short duration of 
anesthesia; and 3) stable anesthetic plane. Its disadvantages include a reasonably well-
documented association with adynamic ileus (loss of GI motility with consequent fluid 
sequestration and constipation) in laboratory rats. In the NIH Animal Program's 
"Anesthesia Guidelines for Rodents", chloral hydrate is specifically listed as an 
acceptable anesthetic for laboratory rat surgery, provided that the concentration of drug is 
kept at 4% or lower, that the users provide an acceptable scientific justification for its use 
in preference to other rodent anesthetics, and that the animal(s) be kept under very 
watchful observation for any signs of adynamic ileus such as bloating or constipation.
Focal cerebral ischemia was produced by permanently occluding the middle cerebral 
artery (MCAo). Under a microscope, the right temporo-parietal region of the head was 
shaved, and an incision was made between the right orbit and the right ear in the shape of 
a “C.” An incision was made superiorly on the upper margin of the temporal muscle. The 
MCA was observed through the semi-translucent skull. A small burr hole was drilled into 
the outer surface of the skull just over the MCA. The inner layer of skull and the dura 
were removed by fine forceps. The MCA was then ligated with 10-0 monofilament nylon 
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suture and transected superior to the ligation point. The small flap of facial skin was 
closed with 6-0 nylon suture.
4.2.2 Assessment of cerebral infarction volume
Two days after pMCAo, the infarction area was measured by 2,3,5-triphenyl-2H-
tetrazolium chloride (TTC) staining as described previously. Mice were decapitated and 
the brains were removed and sliced into 1.0-mm-thick sections using an acrylic mouse
brain block. The brain slices were incubated in a 2% TTC solution for 15 min at room 
temperature and then transferred into a 4% paraformaldehyde solution for fixation. The 
area of infarction in each slice was measured with a digital scanner and Image-Pro 
Analyzer 7.0. The volume of infarction in each animal was obtained from the sum of 
infarction areas in all brain slices examined. 
4.2.3 Behavioral measurements
The stroke-induced neurological deficits or recovery-promoting effects of treatments 
were assessed with sensorimotor tests on days 2, 14, and 24 post-stroke: a modified 
Bederson´s neurological test, elevated body swing test, cylinder test and Rotarod test. In 
these tests, rats display ischemic injury-induced neurological deficits that resolve 
spontaneously over time. The elevated body swing test was carried out as described 
previously (Borlongan et al., 1998). In a short, rats were examined for lateral 
movements/turning when their bodies were suspended 20 cm above the testing table by 
lifting their tails. The most marked body asymmetry seen in stroke animals is 20 
contralateral turns/20 trials. In normal rats, the average body asymmetry is 10 
contralateral turns/20 trials. 
Modified Bederson´s score was used to evaluate neurological deficits as described 
previously (Airavaara et al., 2009). In this test, rats were examined for the degree of 
abnormal posture when suspended 20-30 cm above the testing table. The following scale 
was applied:
0= rats extend both forelimbs straight; no observable deficit
1= rats keep the one forelimb to the breast and the other forelimb is straight 
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2= rats show decreased resistance to lateral push in addition to behavior score 1
3= rats twist the upper half of their body in addition to behavior in score 2 
In the cylinder test, the animal was placed inside a transparent vertical tube with a 
diameter of 35 cm and its movements were video recorded for 5 minutes. The number of 
first front paw touches to the inner wall of the tube, after rising on its hind limbs, were
counted.
Rotarod test: Animals received 3 days of training (twice daily) before MCAo. Each 
animal was placed in the respective lane, 13.75 inches above the testing platform. For 
training, the rod was rotating at 4 r.p.m. initially and then gradually accelerated up to 40 
r.p.m. The test was performed in this accelerated mode 2 days as well as after 7 and 16 
days after MCAo. The cutoff time for each test was 360 seconds. Each animal was tested 
3 times per day. The average endurance times (ETime) on the rotating rod in three trials 
was used for analysis. 
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5 RESULTS
5.1 The expression of MANF in the developing and young adult brain (I and II)
Previously MANF mRNA and protein expression were detected in neurons of different 
areas in the mouse brain. In the present study, we utilized specific MANF antibodies,
validated by comparing wild-type and Manf-/- cortical sections, to analyze the expression 
of MANF by immunohistochemistry during the development of the mouse cortex from 
E13.5 to P35 (I, Fig., 1B; II, Fig., IA). We observed high levels of MANF 
immunoreactivity in the cerebral plate (CP) of E13.5 and E15.5 mouse brains. At E18,
when the laminated structure of the cerebral cortex develops, higher immunoreactivity of 
MANF was found in the middle layer of CP and preserved in the IV/V layer of the cortex
in the postnatal brain. In the cortex of the mature mouse brain, MANF was co-localized 
with NeuN, but not with GFAP, (II, Fig., 1B-C) suggesting that, as earlier shown by 
Lindholm et al (2008), MANF protein is mainly expressed in mature neurons. In addition 
to the cerebral cortex, we further investigated if MANF is expressed in the neurogenic 
area of the mouse brain. From the embryonic stage to adult age, MANF protein was 
preserved in cells with the VZ as well as the SVZ, and colocalized with nestin and DCX,
which are widely used markers for NSCs and neuroblasts, respectively. Importantly, 
MANF is expressed in BrdU-positive cells, indicating that MANF is not only expressed
in post-mitotic neurons but also in mitotic cells in the developing and early adult brain.
5.2 Loss of MANF does not affect the biological properties of NSCs (I)
Since the MANF-expressed VZ and SVZ areas of the brain are composed of NSC/NPCs, 
we wanted to further study the possible role of MANF in cells in the neurogenic region
by setting up primary NSC cultures from E13.5 mouse brains. NSCs are self-renewing,
multipotent cells that generate neurons and glia in the nervous system. Importantly, lack 
of MANF did not affect the viability of NSCs and Manf -/- NSCs continue to survive after 
at least 15 passages in the presence of mitogenic factors. Next, we compared the self-
renewal capacity and proliferation rate between each genotype of NSCs. We found that 
there is no difference in the ratio of BrdU-labeled cells between each group. Also, Manf -
/- NSCs have shown a similar rate of single cells formation of new neurospheres 
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compared to WT (wild-type littermate) cells. Next, we studied whether MANF deletion 
affects the heterogenous population of NSCs and stained WT and Manf-/- NSCs with the 
neural stem cell marker, nestin, and the NPC marker, DCX. There was no difference in 
the numbers of nestin-positive or DCX-positive NSC/NPCs between the two genotypes.
In line with immunostaining results, Western blot analysis showed no difference between 
the genotypes in the amount of nestin, GFAP, or DCX levels measured from NSCs. 
Taken together, the above data demonstrated that MANF-deficiency did not affect 
biological properties of cultivated NSCs, such as heterogeneous populations, self-renewal 
capacity, viability, and proliferation.
5.3 Loss of MANF interferes with neurite outgrowth during neuronal differentiation
(I)
During NSC/NPC differentiation, cellular morphology changes dramatically and there is 
a requirement for protein synthesis for development of branch sprouting and production
of secretory factors. To investigate whether MANF is involved in neuronal differentiation 
and neurite growth in vitro, NSCs were allowed to differentiate in medium without 
mitogenic growth factors (EGF, FGF-2) for eight days. At DIV1, the WT and Manf-/-
cells displayed slightly asymmetrical morphology accompanied by short leading 
processes. At DIV2, WT cells clearly showed neurite outgrowth and there was increased 
neurite extensions at DIV4. In contrast, Manf -/- cells had no obvious neurite sprouting at 
DIV2 and had decreased neurite length at DIV4 (I, Fig., 3B, C), suggesting that loss of 
MANF impaired neurite outgrowth during neuronal differentiation. While a single 
application of rhMANF (200ng/ml) could restore neurite outgrowth of Manf -/- cells at 
DIV2, it did not subsequently increase the neurite length at DIV4. After differentiation,
analysis of total neurite length revealed that Manf -/- neurons displayed significantly 
shorter neurites when compared with WT neurons. As neurite outgrowth is a crucial step 
for neuronal differentiation, we also found that there were significantly fewer TuJ1- and
MAP2-labeled cells with neuronal morphology in the Manf-/- group when compared to 
WT cells at DIV8. The number and morphology of GFAP-positive cells did not differ 
between the two groups (I, Fig., 3D, G), indicating that MANF deletion did not affect 
gliogenesis. In line with the immunocytochemical staining, Western blot revealed 
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decreased protein levels of TuJ1 and MAP2, but not GFAP in the Manf -/- group (I, Fig.,
3I-J).
Given the observed effect of MANF deletion on neuronal differentiation in vitro, we next 
wanted to study whether the lack of MANF disturbs neurogenesis during cortical 
development. Immunofluorescent staining of neuronal nuclei (NeuN), a marker for
postmitotic neurons, microtubule-associated proteins (MAP2), a mature neuron-specific 
marker confined to the soma and dendrites, and neurofilament (NF-200), a neuronal 
cytoskeletal protein supporting axon outgrowth, was carried out. At E19 when cortical 
lamination is developing, few NeuN-positive neurons and MAP2-positive dendrites were 
located at the CP in the WT brain. Since Manf -/- cortex was much thinner, NeuN-positive 
neurons were scarce and tiny MAP2-expressing neurites were visible (I, Fig., 8A-C).
When CP tissue lysates were analyzed by Western blotting, there were no significant 
differences in relative levels of NeuN and MAP2 between each genotype. However, the 
level of neurofilament (NF200) was lower in Manf -/- CP (I, Fig., 8D and E). At P7, when 
cortical neurons have already moved to their destination and develop axonal elongation 
and dendritic branching, there was no difference in the total number of NeuN-positive 
neurons between the two genotypes, but increased neuronal density in the layers II-V of
Manf -/- cortex was observed (I, Fig., 8F-G). In WT neurons MAP2 staining was detected 
in the cell soma and dendrites. In contrast, less MAP2 expression in Manf -/- neurons was 
observed and was limited to the soma (I, Fig., 8I and J). Furthermore, axons from Manf -/-
cortex stained less intensely with the neurofilament marker NF200 compared to WT 
axons (I, Fig., 8K and L). In line with immunostaining data, the level of NF in Western 
blot analysis was reduced by approximately 35% in Manf -/- cortex compared to WT (I, 
Fig., 8M and N). Thus, consistent with in vitro data, loss of MANF during cortical 
development also disturbed dendritic/axonal outgrowth and predominantly decreased NF
production.
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5.4 Loss of MANF results in activation of UPR and decreased de novo protein 
synthesis (I)
Previous studies have indicated that MANF is upregulated under ER stress conditions in 
vitro (Apostolou et al., 2008; Glembotski et al., 2012) and lack of MANF leads to chronic
UPR activation in pancreatic islets in vivo (Lindahl et al., 2014). Therefore, we 
hypothesized that the deficits of neuronal differentiation from Manf -/- NSCs may result 
from aberrant ER activity. First, we studied the level of ER stress and UPR activation in 
WT and Manf-/- cells during neuronal differentiation. At DIV1, the levels of spliced Xbp1
mRNA expression were higher in the Manf -/- group, followed by increased Grp78 at 
DIV4 (I, Fig., 9A, and C). At DIV 8, significant elevations of mRNA levels for Grp78,
Atf4, and spliced Xbp1 were found in Manf -/- differentiated cells (I, Fig., 9D). Also, 
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Manf - /- cells at DIV8 (I, Fig., 9E and F), suggesting loss of MANF indeed results in an 
activated UPR during neuornal differentiation. 
Since ER function is crucial for protein synthesis and processing and UPR attenuates 
protein synthesis, we wanted to study whether MANF deficiecy also disrupts protein 
synthesis when NSCs differentiate. We utilized a homopropargylglycine (HPG)–based 
assay for the detection of nascent protein synthesis. At DIV1, most WT and Manf -/-
NSCs showed strong HPG-derived signals. However, at DIV2, there was less HPG-
derived signal in Manf -/- cells (I, Fig., 9J and K). Importantly, the fluorescent signals in 
WT cells were spread to growing neurites. In contrast, the signals in Manf-/- cells were 
limited to the soma, suggesting that most Manf -/- cells have not yet developed neurite 
sprouting. Collectively, these data demonstrated that deficiency of MANF disturbs ER 
homeostasis, including activated UPR, and further decreases protein synthesis.
5.5 Delayed neuronal migration in MANF-deficient embryos (I and II)
Neural migration, the movement of neuronal precursors from their sites of origin in the 
proliferative layers to their ultimate locations in the mature brain, is a critical step in the 
development of the vertebrate nervous system. Neuronal migration is most likely 
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regulated by different types of extracellular signaling molecules that cells encounter as 
they migrate (Mason et al., 2001). Moreover, cellular movement mechanisms and neurite 
outgrowth play critical roles in initiating and modulating the movement of neuronal 
precursors (Lee et al., 2012). Given that MANF is implicated in axonal outgrowth, we 
wanted to study if MANF-deficiency affects SVZ cell migration. We isolated the SVZ 
from WT and Manf-/- embryos (E19) and cultivated these in Matrigel cultures to 
investigate cell migration out of SVZ explants. Cell migration was examined from WT 
and Manf -/- SVZ explants in vitro. On DIV2, there was little cell migration and no 
difference between each group. On DIV7, Manf-/- SVZ cells had shown shorter migration 
distances compared with WT cells (II, Fig., 2J and K).
Next, we utilized BrdU birth dating to examine neuronal migration in the developing 
cortex. To study the migration of neurons, we injected pregnant Manf +/- mice with BrdU 
at E15.5 and analyzed the embryos at E19. The numbers of Brdu-labeled cells in each 
layer was counted and documented as percentages of total labeled cell numbers. The 
relative number of BrdU-positive cells in the layer V/VI of Manf -/- embryos was 
significantly increased, and was decreased in layer II/III compared to WT littermates (I, 
Fig., 7). Taken together, we demonstrated that MANF is essential for the migration of 
neurons in the embryonic cortex.
5.6 Loss of MANF caused larger infarct volume and increased NSC vulnerability to 
OGD/reoxygenation-induced stress (unpublished data, II)
While MANF has been shown to be protective of cerebral neurons from ischemic injury 
in the model of transient MCAo in rat, it is not clear if MANF’s effect is mediated
through a direct action on neurons or microenvironment modulation. In this work
(unpublished data), we established the permanent MCAo model of cortical stroke and 
analyzed infarct volume in adult Manf flox/flox(fl/fl) (WT) and NesinCre/+:Manf flox/flox(fl/fl)
(MANF-cKO) (8-10 weeks). By using TTC staining on day 2 post-stroke, MANF-cKO 
mice displayed a larger infarction volume than their WT littermates (Fig., 6), suggesting 
that endogenous MANF has the potential to protect cortical neurons from ischemic 
injury. 
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Figure 6. TTC staining on day 2 after dMCAO. MANF-cKO mice displayed a larger infarction volume 
than the WT littermates. Values shown are the mean± SD. ***p< 0.001 between WT and MANF-cKO 
mice (n=7-9).
To further study whether MANF also has a potential to protect NSCs from stress insults, 
we set up the hypoxic model with 40-min oxygen-glucose-deprivation (OGD) followed 
by 24-hours reoxygenation. Propidium iodide (PI) was detected by means of flow 
cytometry in Manf+/+ - and Manf-/--NSCs exposed to OGD/reoxygenation. PI is a
fluorogenic compound that binds stoichiometrically to nucleic acids so that fluorescence 
emission is proportional to DNA content of a cell (Wallen et al., 1982). When apoptotic 
cells are stained with PI and analyzed with a flow cytometer, they display a broad 
hypodiploid peak, which can be easily discriminated from another peak of cells with 
normal (diploid) DNA content in red fluorescence channels (Ormerod et al., 1992). In 
normoxic conditions, the percentage of PI-positive cells were not significantly different 
between Manf+/+ and Manf-/- NSCs (Fig., 7A& B; 24.85%±2.85 (n=6) vs 25.16%±1.32
(n=6), respectively). In Manf-/- NSCs, 40 minutes of OGD followed by 24 h of 
reoxygenation caused a significantly higher increase in the number of PI-positive cells, 
compared to Manf +/+ NSCs (Fig., 7C& D; II, Fig. 2J). Next, we assessed whether
recombinant human MANF (rhMANF) can rescue OGD-induced apoptotic cells.
Compared to Manf -/- NSCs, pre-treatment of MANF significantly decreased the 
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percentage of PI-positive cells (Fig., 7E& F; II, Fig. 2J), implying loss of MANF 
increases NSC vulnerability to OGD stress. However, in WT cells, the administration of 
MANF did not improve cell viability. Therefore, the above data suggests that loss of 
MANF increases OGD-induced cell apoptosis and administration of rhMANF could, at 
least partially, restore the function of MANF in Manf -/- NSCs.
Figure 7. Analysis of NSCs apoptosis by propidium iodide (PI) staining and flow cytometry. The left panel 
shows that dot-plot analysis of WT (A) and Manf -/- (B) NSCs/NPCs in the normal condition undergoing 
apoptosis. Apoptotic cells can be recognized by lower diameter (FS) and increased DNA fluorescence 
compared to normal cells. The right panel reveals a precise and reproducible estimate of percentage of 
normal and apoptotic nuclei, which can be obtained by analysis of the DNA histogram. The flow 
cytometric and DNA histogram plots show the presence of more characteristic hypodiploid nuclei when 
death of Manf -/- cells was produced by OGD treatment (D), compared to WT group (C).? The 
normal/apoptotic nuclei of MANF-treated WT (E) and Manf -/- (F) NSCs, induced by OGD/reoxygenation, 
are shown in flow cytometric plots and DNA histogram of the peaks corresponding to the normal and 
apoptotic nuclei.
5.7 Administration of MANF induces differentiation of NSCs (II)
Our studies, described above, show that loss of MANF leads to disturbed neuronal 
differentiation, including shorter neurite outgrowth. Next, we wanted to study if 
exogenous application of rhMANF affects the biological properties of NSCs. To 
investigate the effects of extracellular MANF, rhMANF (400 ng/ml) or vehicle (PBS) as 
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added to the WT and Manf-/- NSC cultures from DIV1-4. First, we analyzed the diameter 
of neurospheres and found no difference in the size of neurospheres between each group. 
However, many rhMANF-treated WT and Manf-/- NSCs showed localized budding and
cellular processes attaching to the surface of petri dishes, implying that these changes 
preceded morphologic changes. Immunofluorescent staining revealed that there was 
similar immunoreactivity for nestin, a neural stem cell marker, between each group. 
There was strong expression of TuJ1, a marker of immature neurons, and GFAP, a
marker for glial cells, in the rhMANF-treated neurospheres (II, Fig., 2E and F). Western 
blot analysis also showed increased levels of neuron-specific tubulin and glial-associated 
intermediate filament in the MANF-treated group. Accordingly, our data demonstrated 
that exogenous application of MANF did not affect neurosphere formation derived from 
proliferating NSCs, but induced filopodia changes accompanied by increased neuronal-
and glial-associated cytoskeletal proteins which is crucial for the early step of 
neuronal/glial differentiation.
5.8 MANF promotes migration of SVZ cells (II)
Since endogenous MANF is essential for embryonic SVZ cell migration, we wanted to 
study if administration of MANF further promotes cell migration from postnatal SVZ 
explants. First, we added rhMANF protein (200, 400 and 800ng/ml) to the SVZ explant 
cultures from DIV1 to DIV5. On DIV7, we found that application of rhMANF (200 
ng/ml and 400 ng/ml) increased the cell migration distance from SVZ explants, when 
compared with the vehicle (PBS) group (II, Fig., 4C, D). However, 800 ng/ml rhMANF
did not have a significant effect on SVZ explants, implying that exogenous MANF 
regulated the migration of SVZ cells in an inverted “U” dose-dependent manner. 
Next, we wanted to study whether endogenous overexpression of MANF in NPCs has 
similar effects on cell migration. Therefore, we produced lentiviral vector (LV)-mediated 
overexpression of MANF that contains RTDL (hMANF) or lacks the RTDL sequence
(deltaRTDL). To verify the transduction of viral vectors, we transduced developing 
cortical neurons with LV-hDCX-GFP, LV-hDCX-hMANF-GFP, or LV-hDCX-MANF 
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(deltaRTDL)-GFP. Using a sensitive enzyme-linked immunosorbent assay (ELISA), we 
found that 5 days after transduction by LV-hDCX-hMANF-IRES–GFP, LV-hDCX-
MANF (deltaRTDL)-GFP, the levels of hMANF in developing cortical neurons and 
media were significantly increased compared with naïve cells or cells transduced by LV-
hDCX-GFP (Fig., 8A). Interestingly, the developing cortical neurons transduced by LV-
hDCX-hMANF-IRES–GFP and by LV-hDCX-MANF (deltaRTDL)-GFP had similar 
hMANF concentrations in the medium (Fig., 8B), suggesting that deletion of the RTDL 
sequence does not increase the secretion of hMANF from cells under these conditions.
The cultured SVZ explants were transduced by LV-hDCX-GFP, LV-hDCX-hMANF-
IRES-GFP, or LV-Dcx-hMANF (deltaRTDL)-IRES-GFP on day 1 (DIV1). On DIV6, 
overexpression of MANF induced a longer distance of cell migration than the naïve or 
GFP group (Fig., 8C). Moreover, overexpression of MANF-deltaRTDL showed similar 
effects on SVZ cell migration, implying that the RTDL motif is not required for MANF-
promoted SVZ cell migration. 
Next, we investigated which molecular mechanism is involved in the MANF-promoted 
migration of SVZ. We found overexpression of MANF significantly activated the p-
ERK/ERK pathway and induced the phosphorylation of STAT3-SER727 on DIV4 (II, 
Fig. 6G, I and J-L), but had not increased p-AKT and p-S6K levels (II, Fig. 6H, I). In 
addition, there was no difference in GRP78 protein levels between groups at any time 
points, though MANF has been implicated in regulating UPR markers. Together, these 
results suggest that overexpressed MANF in DCX+ cells would induce STAT3 and 
ERK1/2 activation when cells start to migrate from SVZ explants.
56
Figure 8. Transduction of SVZ cells with LV-MANF or LV-MANF (delta RTDL) enhances cell migration 
from SVZ explants derived from P1 mouse brain. MANF protein concentration in cell lysates (A) and 
culture media (B) from embryonic cortical neurons transduced with indicated LVs (1-way ANOVA, *** 
p<0.001 compared to GFP, TK). C, Quantified migration distance at DIV1 in all groups (n=4-5) and at 
DIV6 revealed increased cell migration from SVZ explants transduced with LV-MANF and LV-MANF 
(delta RTDL) as compared to the Naïve, GFP groups (n=11-12, 1-way ANOVA, p=0.02; * p<0.05). Data 
are expressed as the Mean ± S.E.M.
5.9 MANF promoted the migration of DCX+ cells toward the infarct boundary (II)
Since our studies showed that MANF treatment induced SVZ cell migration in vitro, we 
wanted to study if application of MANF protein could also have the potential to promote
NPC migration toward the ischemic area after cortical stroke. Stroke rats were 
stereotaxically injected into right lateral ventricles with GDNF, rhMANF or vehicle (1x 
PBS) on days 3, 7 and 10 after dMCAo. As expected, GDNF treatment increased density 
of DCX immunoreactivity (neuroblasts) in the ipsilateral SVZ. In contrast, MANF 
treatment did not increase the number of DCX+ cells in the SVZ compared to the vehicle 
group. However, application of rhMANF significantly increased the numbers of DCX+
cells in the corpus callosum and infarcted neocortex (II, Fig., 7J-M). Additionally, 
MANF induced large chains of neuroblasts with long, branched processes in the corpus 
callosum beneath the infarction zone. Taken together, the above data revealed that the 
administration of MANF protein into the right lateral ventricle facilitated migration of 
neuroblasts to the injured cortex.
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We next explored whether MANF, compared to GDNF, influences the fate of newly 
generated cells 14 days after cortical stroke. MANF treatment markedly increased the 
number of cells labeled with BrdU and DCX in the corpus callosum beneath the 
infarction zone, compared to vehicle and the GDNF-treated group (II, Fig., 8A, B). There 
was a trend towards fewer cells double-labeled with BrdU and the astrocyte marker 
GFAP, in the infarcted area of neocortex after MANF treatment (II, Fig., 8C, D). 
Meanwhile, the number of BrdU+ cells co-expressing the oligoprogenitor cell marker 
NG2 was not different among the three groups (II, Fig., 8E, F). Thus, the administration 
of MANF after cortical stroke may have selectively affected the migrating immature cells 
of the neuronal lineage.
5.10 Long-term infusion of MANF increased recruitment of DCX+ cells in infarcted
cortex and accelerated behavioral recovery (II, unpublished data)
After determining the effects of MANF and GDNF on DCX+ cell migration in cortical 
stroke, we next examined the efficacy of long-term treatment of MANF or GDNF for
experimental ischemic stroke. Therefore, using osmotic minipumps, GDNF, MANF, or 
vehicle were infused into the peri-infarction zone for post-dMCAo days 3-16 and the rats 
were euthanized one week later (II, Fig., 9A). Lesion size did not differ among three 
groups. As expected, GDNF, a classical chemoattractant, increased the number of DCX+
cells in the infarct area of the striatum (Kobayashi et al., 2006). Interestingly, MANF 
treatment also promoted the recruitment of neuroblasts in the lesioned cortex (II, Fig., 9H 
and I). Then, we continued to explore whether MANF or GDNF increased the 
differentiation of progenitor cells into cortical neurons by labeling them with BrdU, and
with a marker for mature neurons (NeuN). MANF or GDNF treatment failed to further 
increase the number of newly-generated cortical neurons (Brdu+/NeuN+ cells) in the 
peri-infarct area on day 24 (II, Fig., 9J and K). Finally, we analyzed the behavior of rats 
after administration of MANF and GDNF in the peri-infarct area (unpublished data). All 
stroke rats were examined on days 2, 7, 14 and 24 after MCAo. Before treatment, all 
animals demonstrated close to 100% body asymmetry at 2 days after pMCAo. In MANF-
treated rats, there was a significant reduction in body asymmetry on day 24 post-stroke
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(Fig., 9A). However, in GDNF-treated rats, there was no improvement in body 
asymmetry at different time points. Modified Bederson’s neurological test was carried 
out on days 2, 7, 14, and 24 after MCAo. In stroke animals, no significant difference was 
found among each group at different time points, though the MANF treatment had a trend 
towards reduced Bederson’s score on day 24 post-MCAo (Fig., 9B). Cylinder test studies 
involved the use of contralateral paws (i.e. left) evaluated for 10 minutes on day 2, 14, 24 
post-stroke. In cylinder test, the MANF-infused rats showed, compared to the PBS- or 
GDNF-infused rats, a higher frequency of using their left forepaw to touch the plexiglas 
cylinder on both days 7 and 14 post-stroke (Fig., 9C). Taken together, these data suggest 
that chronic infusion with MANF, but not GDNF, could induce behavioral improvement 
in stroke animals.
Figures 9. Long-term infusions with MANF after stroke induces behavioral recovery. The severity of their 
neurological deficit was assessed on days 7, 14, and 24 using the body swing test (B) and Bederson’s 
neurological test (C). According to two-way ANOVA (F (6, 46) = 2,527; P=0.033), the difference in the 
number of body turning to contralateral side of the lesion were statistically significant on day 24 after 
stroke. The percent of left forepaw use of PBS, GDNF, and hMANF-infused rats as determined using the 
cylinder test. According to two-way ANOVA (F (2, 36) = 3,532; P=0.039), the differences in left forepaw 
use were statistically significant. Chronic infusions of MANF significantly decreases left forepaw use on 
days 14 and 24 after stroke. Data are expressed as the Mean ± S.E.M.
5.11 Pre-stroke administration of AAV-BDNF to the contralateral SVZ did not alter 
the size of infarction, but induced NPC migration to the lesioned hemisphere (III)
Abundant experimental data have supported the idea that BDNF has beneficial effects in 
animal models of stroke. For example, intraventricular administration of BDNF was 
shown to reduce infarct size after focal cerebral ischemia in rats. Similarly, pretreatment 
with AAV (serotype 2)-BDNF, given i.c.v., had a neuroprotective function. However, 
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these data were contradicted after the systemic administration of BDNF, which did not 
affect infarct size. This discrepancy indicated that the neuroprotective function of BDNF 
is dependent to the administrative route or location. To better understand the therapeutic 
effect of BDNF, AAV-BDNF or AAV-GFP was injected locally to the left SVZ at 14 
days prior to the right MCAo in rats. We found that AAV-BDNF delivered to the SVZ 
contralateral to MCAo did not alter the size of infarction (Fig., 10); however, there was 
enhanced endogenous NPC migration from the SVZ toward the lesioned hemisphere. (III, 
Fig., 3 and 4). Therefore, these data demonstrated that BDNF’s trophic response is 
limited to the site of injection.
Figures 10. TTC staining on day 2 after dMCAO. AAV-BDNF treatment displayed a similar infarction 
volume compared to the AAV-GFP. Values shown are the mean± SD. (n=7-9).
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6 DISCUSSION
6.1 A critical review of the methods used
6.1.1 Neurosphere culture
The neurosphere culture is a widely used cell model for studying the biological properties 
of NSCs, such as proliferation and differentiation in vitro. Much of the currently 
available information regarding these features derive from studies utilizing this cell 
model. In this study, NSCs from embryonic mice were used. Mouse embryos are easily 
available and the preparation of cortical progenitors from embryonic mice is 
straightforward. The mouse is also a good model to study human development and 
disease as it shows considerable similarity to human anatomy and physiology, including 
the structure and development of the cortex (Ayala et al., 2007; Bystron et al., 2008). The 
use of mice also allows for modification of the mouse genome, something that is not 
easily available in humans. In this study, we utilized mice with ablation of the Manf full-
length transcript for studying the role of MANF in NSC development.
Isolation of embryonic stem/progenitor cells by dissection of the dorsal wall of the lateral 
ventricles were used followed by enzymatic dissociation and subsequent rounds of 
centrifugation through various solutions to purify the NSCs. After dissociation, the 
NSCs/NPCs were grown in suspension culture in the presence of mitogens. Any 
contaminated cells adhering to the bottom of the culture vessel were removed upon re-
plating of the cells in a new culture vessel. Just like with other cell culture systems, the 
neurosphere culture system has its advantages and disadvantages (Jensen and Parmar, 
2006). The proliferation of cells is affected by cell plating density (Tropepe et al., 1999).
In addition, the composition of growth media and concentration of intrinsic and extrinsic 
factors, such as EGF and FGF, affect cell proliferation and differentiation (Irvin et al., 
2003). The method of passaging (enzymatic or manual) may also affect the properties of 
cells, as do the passage number as the cells tend to lose their neurogenic potential, and 
become more gliogenic upon long-term cultivation. The reason for this remains 
unknown. We made use of the fact that neurospheres can be frozen, thus allowing us to 
freeze neurospheres at early passage to be thawed when the existing culture grew older. 
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The high sensitivity of the culture system to the external environment may lead to 
difficulties in comparing research results obtained by different laboratories. The 
neurospheres are also heterogeneous in nature, consisting of cells at various stages of 
differentiation (Jensen and Parmar, 2006). Thus, one should not consider the neurosphere 
system as a model for studying pure stem cells but as a model to study various 
stem/progenitor cells arising within the neurospheres. Nevertheless, the neurosphere 
system does provide a valuable model to study neural development in vitro. Importantly, 
it has been demonstrated that cortical progenitor cells expand as neurospheres in a similar 
manner as they do in vivo (Shen et al., 2006). The intrinsic properties of neurospheres, as 
well as the fact that they are grown in defined conditions, provide a model system that 
allows for the study of forebrain development, adult neurogenesis, and factors affecting 
these processes in cell cultures.
6.1.2 SVZ explant culture
In this study, we used SVZ explant cultures to assess the role of MANF in regulating the 
intermediary stage of neural/progenitor cell migration. There are a number of advantages 
in using explant cultures over in vivo and other in vitro methods. First, cells in explanted 
tissues are accessible to experimental manipulations easily (Chen et al., 2005). Second, 
the fact that explants maintain the complex cellular architecture of developing neural 
tissue means that cell-cell interactions can be studied (Yin et al., 2016). Third, since we 
can control the chemical composition of the culture medium, we can use explants to test 
the effect of specific compounds on tissue development (Mani et al., 2010). Nevertheless, 
since cells are removed their natural environment, this culturing system relies on the 
presence of growth factors to maintain undifferentiated status. Withdrawal of these 
induces rapid differentiation into mature cells. This condition limits the ability to analyze 
the factors that regulate type A neuroblasts, a transient stage between the stem cell and
the neuron. To counteract this limitation, pieces of SVZ-derived tissue can be harvested 
and cultured as explants in a Matrigel containing laminin and collagen, which maintains 
the neural stem cells in their neuroblast condition and allows them to migrate (Ward and 
Rao, 2005; Dixon et al., 2015).
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6.1.3 Rodent models of focal cerebral ischemic injury
There are many animal models of focal cerebral ischemic injury available. While rats 
have been a commonly used species for preclinical neuroregenerative trials for ischemic 
injury, mice with genetic modifications also provide an excellent approach to help 
determine potential mechanisms of injury and neuroprotection (Sommer, 2017).
Most cases of human ischemic stroke are caused by occlusion of the MCA or one of its 
branches (Carrera et al., 2007). This is reflected in animal models of stroke where MCAo 
is the most widely used technique. Recently, focal ischemia induced by thromboemboli 
has also been of interest because of its resemblance to human ischemic stroke and its role 
evaluating thrombolytic therapy (Sicard and Fisher, 2009). However, the infarct size is 
variable and ischemia caused by multiple small clots do not mimic typical clinical 
ischemic stroke (Sicard and Fisher, 2009). Therefore, the size and characteristics of blood 
clots are crucial in this model. Another common way of producing MCAo in rats and 
mice is by the use of an intra-arterial filament. This method results in relatively low 
animal-to-animal variation in infarct size. However, this approach causes a bigger injury
that compromises the striatum, cortex and even thalamus/hypothalamus. Injury to the 
hypothalamus is rare in human cases, and it also causes hyperthermia that may interfere 
with the analysis for neuroprotective efficacy of drugs (Li et al., 1999).
In this study, we have used the craniotomy model of distal MCAo together with the 
bilateral occlusion of the common carotid arteries to reduce collateral blood flow (namely 
the three-vessel occlusion model) (Durukan and Tatlisumak, 2009). The craniotomy 
model requires removal of a piece of skull overlying the MCA so that it affects 
intracranial pressure and BBB integrity as well as causing a small amount of 
subarachnoid hemorrhage around the MCA trunk. However, it provides a direct exposure 
window to ligate the distal part of the MCA, which supplies the neocortex. Simultaneous 
occlusion of the MCA and the ipsilateral common cerebral artery, combined with 
transient occlusions of the contralateral common cerebral artery, leads to good 
reproducibility of infarcts (Tamura et al., 1981). This distal MCA occlusion model 
produces an infarct core in the frontal and parietal cortex, and an evolving infarction over 
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3-4 days in the adjacent temporal and cingulate cortex as well as the dorsolateral 
striatum. The injury is characterized by leukocyte infiltration, cytokine production, 
caspase activation and apoptosis (Durukan and Tatlisumak, 2009; Sommer, 2017).
Additionally, in this MCAo model the occlusion can be either transient or permanent. To
maintain the infarct cortical size, we have chosen to use a transient 90-minute occlusion 
in our rat model. For transgenic mice, we also adapted a standardized protocol for 
performing permanent distal MCAo, which produces an infarct predominantly restricted 
to the barrel region of the somatosensory cortex.
6.2 The neuroregenerative effect of BDNF after stroke
Experimental data has supported the idea that BDNF has beneficial effects in an animal 
model of stroke, reducing the size of brain infarction and improving functional recovery
(Schabitz et al., 1997). BDNF has also been shown to enhance the neurogenesis and the 
migration of NPCs in SVZ in non-lesioned animals; the migration is mainly toward the 
olfactory bulb (Chiaramello et al., 2007). Limited reports indirectly support the effect of 
BDNF on SVZ cell migration in stroke animals. For example, systemic administration of 
BDNF enhanced recruitment of NPCs into ipsilateral striatum after stroke (Schabitz et al., 
2007). However, systemically applied BDNF can interact with multiple anatomical sites. 
It is not clear if the improvement in cell migration is mediated through an action in SVZ 
or the target of lesioned sites. In this study, we demonstrated local AAV-BDNF delivered 
to the SVZ contralateral to MCAo did not alter the size of infarction, but directly 
enhanced endogenous NPC migration from SVZ as well as improved functional recovery 
in stroke animals. These results may provide a new treatment target in non-lesioned side 
SVZ for stroke patients through gene or recombinant protein therapy.
6.3 The role of MANF in ER function during neuronal differentiation 
In this study, we discovered that when cultured in vitro, MANF-deficient cells have 
impaired neurite outgrowth during neuronal differentiation. In contrast to other classical 
neurotrophic factors such as GDNF and BDNF, MANF is an ER luminal protein, which 
is secreted in response to ER stress in vitro (Hellman et al., 2011). Thus, MANF can be
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considered an ER-stress-inducible protein which has a protective effect under brain 
ischemic, neurodegenerative, and apoptotic conditions (Apostolou et al., 2008; Airavaara 
et al., 2009; Voutilainen et al., 2009) . During neuronal differentiation, neurites acquire 
their morphology by considerable branch sprouting, which comes with an increased need 
for protein production (Godin et al., 2016). Increased protein synthesis and accumulation 
of unfolded or aggregated proteins triggers the UPR, a homeostatic signaling pathway, to 
cope with the increased demand for protein folding. However, constitutively increased 
ER stress and activated UPR disturb homeostatic signaling pathways in the ER which can 
cause aberrant neuronal differentiation, impair neurite outgrowth, and may even result in 
cell death (Kawada et al., 2014; Kawada et al., 2016). Accordingly, the level of ER stress 
and downstream UPR signals are critical for neuronal differentiation (Kurosawa et al., 
2007). In our experiments, aberrant UPR signals and decreased protein synthesis were 
observed during Manf -/- NSC differentiation. While the downstream targets of the UPR 
pathways are not well studied ??? ???????????????? ????????? ?????????? ??????
phosphorylation, known to lead to a global decrease in mRNA translation initiation
(Lindahl et al., 2014), and ATF4 up-regulation, which disrupts cAMP–induced responses,
play crucial roles in neuronal differentiation (Roffe et al., 2013). Accordingly, we 
assumed that endogenous MANF acts like a chaperon in the ER to fine-tune downstream 
UPR signals and preserve ER homeostasis, which is crucial for nascent protein synthesis 
and processing during neuronal differentiation and neurite growth (Fig., 11).
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Figure 11. Schematic role of MANF in ER homeostasis during neuronal differentiation, maturation and 
migration. Adapted and reprinted by permission from Society for Neuroscience.
6.4 The role of endogenous MANF in corticogenesis
Drosophila melanogaster embryos lacking both maternal and zygotic DmMANF show 
axonal degradation of dopamine neurons (Palgi et al., 2009). However, it is important to 
note that DmMANF is predominantly expressed in glial cells surrounding dopaminergic 
neurons, which indicates that the neuronal maturation-promoting factor in the fly 
orignates from glial cells (Palgi et al., 2009; Palgi et al., 2012; Lindstrom et al., 2016). In 
contrast to invertebrate species, MANF protein in the mammalian brain is widely 
localized in NSCs, NPCs, and immature/mature neurons, but not in glial cells, suggesting
that MANF is predominantly expressed in the neuronal lineage cells of the mammalian 
cortex (Lindholm et al., 2008; Wang et al., 2014). Similar to the results seen in vitro,
deletion of MANF in the developing cortex causes a deficit in neurite outgrowth, 
especially neurofilament-expressed axonal extension. However, there is no decrease in 
the generation of cortical neurons in the mutant cortex despite delayed subtype neuron 
specification and abnormal neuronal density due to a 10% reduction of Manf-/- cortical 
thickness. To elucidate more fully the effects of MANF on cortical development, we also 
quantified relative levels of GRP78, ????????? ??? ????????? ??? ????????? ???? ????? ???
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Western blot analysis in the CP at E19 and in the cortex at P6 (unpublished data). Higher 
level of GRP78, but not ???????????????????????????? was observed in Manf-/- CP at E19.
By P7, both of GRP78 and (p)eIF2? were shown to be significantly increased in Manf -/-
cortex. Similar to in vitro data, UPR activation is progressive and constitutive during 
cortical development. Accordingly, we assumed that in vivo there might be another 
compensating mechanism, as yet unknown, to reverse an aberrant UPR-induced 
disturbance during Manf -/- neuronal maturation. Future studies will be required to 
address a more mechanistic understanding of corticogenesis as related to ER stress.
6.5 The role of MANF in neuronal migration
In this study, we demonstrated that MANF is required for the migration of neurons to 
their final destinations in specific layers of the cortex. In contrast to reeler and related 
mutant mice (Mimura et al., 2008), the development of Manf -/- cortex shows an inside-
out laminar formation pattern. Additionally, there is no truncated or reduced organization 
of radial glial cells observed in the Manf -/- cortex. Since previous studies have 
demonstrated that neuronal migration and neurite outgrowth are correlated and are 
dependent on the same molecular mechanisms (Yamasaki et al., 2011; Lee et al., 2012),
we assumed that loss of MANF, impairing neurite outgrowth, also caused delayed 
cortical neuron migration in the developing cortex.
To further elucidate the mechanistic action of MANF in cell migration, we tried to
manipulate the level of MANF in the NPCs by isolating SVZ explants from conventional 
knockout mice lacking MANF mRNA, and by supplementing with exogenous MANF or 
overexpression of endogenous MANF in DCX+ cells. SVZ cells lacking MANF showed a
shorter distance of migration as compared with WT cells. Also, we found that 
administration of MANF could induce neural/glial differentiation accompanied by the 
morphological change of a bipolar shape as well as promotion of cell migration out of 
SVZ explants. These data again suggest a critical role of MANF in the differentiation of 
NSC/NPCs and development of neurite-like and glial processes, and subsequently the 
migration of SVZ cells. The results of deletion of MANF in NPC cultures imply that 
MANF deficiency-induced activated UPR signals could be implicated in neurite 
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outgrowth and indirectly interfere with the process of neuronal migration, although
exogenous MANF administration in NPC cultures did not alter the UPR signals 
compared to the naïve control. Accordingly, the downstream pathways of MANF might 
be not only in UPR regulation, and would need to be further investigated.
6.6 Possible mechanisms of MANF´s action 
To date, MANF has been found to calcium-dependently interact with the ER chaperon 
GRP78, but is released from GRP78 and secreted upon ER stress which results from 
depletion of ER calcium. However, there is no direct evidence that MANF, like GRP78, 
is involved with ER transmembrane receptors to regulate the UPR. Additionally, the 
signaling pathways for MANF have remained largely unclear, though prior studies have 
shown that administration of an extremely high dose of recombinant MANF increased 
PKC phosphorylation in PC12 cells in a time-dependent manner (Yang et al., 2014a).
PKC has multiple effects, and its activity modulates many downstream molecular 
pathways (Corbit et al., 2000), such as MAPK (Corbit et al., 1999). In this work, we first 
showed that intra- and extracellular administration of MANF has the potential to enhance 
cell migration from SVZ explants. Moreover, the MANF-overexpressed DCX-positive 
cells form chain-like structures extending outside of SVZ explants, suggesting that 
MANF may induce neuroblasts to exhibit migratory morphology. This finding led us to 
hypothesize that MANF may regulate intracellular signals to exert its effect on cell 
migration. While overexpressed MANF does not affect the levels of phosphorylation of 
AKT and the downstream ribosomal protein S6, it triggers phosphorylation of STAT3
and ERK1/2 activation in cells migrating out of SVZ explants. STAT3, a classic 
transcription regulator, was first discovered as a key mediator of cytokine-induced 
inflammation and immunity (Yu et al., 2009). Later studies found that STAT3 regulates a
much wider range of biological processes, including determining the fate of NSCs. GFAP 
expression during glial differentiation from NSCs is dependent on the activation of 
STAT3, especially on the phosphorylation at Tyr705 of STAT3 (Xia et al., 2002).
Moreover, activation of STAT3 is crucial for neuronal differentiation because 
cytoplasmic STAT3 can modulate the microtubule network by antagonizing the 
microtubule destabilization activity of stathmin (Ng et al., 2006). Furthermore, a number 
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of studies have shown that serine-phosphorylated STAT3 is localized to the mitochondria 
instead of the nucleus (Islam et al., 2009; Zhou and Too, 2013), which is involved in 
NGF-induced neurite outgrowth (Zhou and Too, 2011). In this study, administration of 
exogenous rhMANF to neurosphere cultures and overexpression of endogenous hMANF 
in SVZ explants induced activation of STAT3, implying that MANF can regulate the
STAT3 pathway to promote NSC differentiation and progenitor cell migration. Recent 
evidence suggests there may be an important interaction between the UPR receptors and 
STAT3 signaling. For example, STAT3-activating cytokines, such as IL6, increase the 
expression of GRP78, a key regulator of UPR activation, but does not induce ER stress
(Vollmer et al., 2010). Also, in astrocyte cultures, STAT3 is activated through a novel 
PERK-JAK1 pathways to regulate ER-induced inflammation (Meares et al., 2014). Does 
MANF induce activation of STAT3 signaling in NSC/NPCs through interacting with ER 
transmembrane receptors to affect the JAK-STAT3 pathway or by direct phosphorylation 
of JAK1? Additional studies will be required to address these questions. Although the 
overexpression of MANF also caused ERK1/2 phosphorylation in SVZ explants, we do 
not know whether this activation was directly induced by MANF or STAT3-related 
downstream targets. Since STAT3 upregulates gene expressions of growth factors, such 
as ?????????????? ????????????? ????? (Sakata et al., 2012), we assumed the ability of 
MANF to induce STAT3 activation not only promotes NSC differentiation, but also 
increases the levels of these growth factors, which mediate the ERK1/2 pathway to exert 
the stimulatory effect on the cell migration. Further studies will be required to identify
putative MANF receptors in NPCs and the specific contribution of MANF-activated 
STAT3 to exert these effects.
6.7 The effect of post-stroke MANF and GDNF on neurogenesis and functional 
recovery
Our better understanding of MANF’s roles in the biological properties of NSCs/NPCs
encouraged us to utilize the beneficial effect of MANF on these cells for optimizing 
endogenous stem cell-based therapies to repair the damaged CNS. In order to identify the 
adult NPC behavior underlying the effect of MANF treatment, we turned to an unbiased 
approach of comparing MANF with GDNF treatment after cortical stroke. GDNF 
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increased cell proliferation and the number of neuroblasts in the SVZ, but not at the 
infarct boundary on day 14 after stroke, which is not similar to a previous finding that 
GDNF administration enhanced recruitment of neuroblasts in ischemic lesions
(Kobayashi et al., 2006). There are several possible explanations for this discrepancy. 
First, we performed MCAO by ligation of the right MCA and bilateral common carotid
arteries for 90 min, which produces the ischemic lesion mainly in the neocortex without 
compromising the striatum. On the other hand, Kobayashi and coworkers used the
intraluminal filament technique to produce a larger infarct, including the striatum and 
neocortex. This suggests that increased cell proliferation and neuroblast numbers could 
have been caused by more extensive damage (Kobayashi et al., 2006). Second, the 
infusion sites of GDNF were different. In our study, GDNF was infused into the lateral 
ventricle, whereas Kobayashi and coworkers infused GDNF intrastriatally so that GDNF 
diffused throughout the striatum, including the SVZ. Therefore, recruitment of more 
neuroblasts to the infarcted striatum may result from a chemoattractant effect or 
secondarily due to an increase in the number of neuroblasts in the SVZ (Kobayashi et al., 
2006). Previous studies have shown that MANF and GDNF have different diffusion and 
transport profiles after intracerebral injection. Compared to GDNF, the volume of 
distribution of MANF is significantly larger and more MANF is transported to the frontal 
cortex after intrastriatal injection (Voutilainen et al., 2009). Since distribution capacity is 
related to efficacy of neurotrophic factors, the lower benefits of GDNF and NRTN, with 
their limited tissue distribution, have been shown in recent clinical trials in 
neurodegenerative disease. Therefore, it could be hypothesized that the increased 
migration of neuroblasts from the SVZ toward the infarct area of the neocortex seen here 
is attributed to a direct effect of MANF on neuroblast activity and a better distribution or 
more efficient transportation of MANF in the cortex. In particular, MANF did not affect 
proliferation of SVZ cells after stroke, which may be of importance for possible clinical 
use of MANF because almost all growth factors could induce dysplasia from 
uncontrolled cell proliferation. 
To determine the effect of long-term MANF treatment on forebrain neurogenesis in the 
stroke model, we used local infusion of MANF to analyze DCX+ cells in the infarct area 
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and compared it with GDNF. Similar to GDNF treatment, local infusion of MANF also
increased the number of DCX+ cells in the infarcted cortex. This likely reflects an 
environment that is more conductive to maintenance of neuroblasts by promoting cell 
survival rather than enhanced migration toward this region. Although local differences in 
microenviornments between brain regions are not surprising, the actual source of 
difference that would account for this change in neuroblast maintenance is unclear.
In addition, MANF and GDNF did not significantly increase the number of newly-
generated neurons in the peri-infarct zone, implying that almost all migrating NPCs had
not yet differentiated to mature neurons on day 24 after stroke. In our study, the infusion 
of MANF or GDNF continued for up to 16 days, similar to the temporal pattern of 
ischemic-induced neurogenesis and neuroblast migration described previously. As levels
of MANF or GDNF decreased due to withdrawal of supplementation, migrating 
neuroblasts in the injured cortex might halt or fail to differentiate into mature neurons. 
Finally, MANF treatment, but not GDNF, was shown to induce behavioral improvement 
after stroke. Since post-stroke inflammation has been implicated in MANF treatment 
(Tobin et al., 2014), it is possible that the effects of MANF on behavioral improvement 
are mediated by immune modulation (Chen et al., 2015a; Stratoulias and Heino, 2015).
Indeed, recent reports have suggested that MANF has an immunomodulatory function to 
improve the success of cell-replacement regenerative therapies in the retina (Neves et al., 
2016). Further studies are needed to determine the roles of MANF in mediating 
inflammation and increasing recruitment of NPCs in the lesioned cortex to develop better 
therapeutic strategies for brain injury.
6.8 The therapeutic application of MANF for stroke: challenges and prospects
Although MANF was discovered in 2003, our knowledge about the basic biology, mode 
of action and therapeutic potential of this unique neurotrophic factor is still limited
(Lindahl et al., 2017). The major challenge is to understand the mechanism of action of 
this protein. Compared to other NTFs this is very challenging since MANF acts inside the 
cell and most obviously also as an extracellular protein (Glembotski et al., 2012). When
MANF was applied as an extracellular protein or delivered by viral vector, it had 
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neuroprotective effects in rodent models of cerebral ischemia (Airavaara et al., 2009; 
Airavaara et al., 2010). These promising results raise hopes that MANF can be developed 
as a novel drug for treatment of ischemic stroke, but several challenges still remain. So 
far, all neuroprotective agents have failed to show any benefits in humans (Wu, 2005; 
Uzun et al., 2010). Although there are multiple underlying reasons for the failure, the 
BBB is an important issue and will continue to be a hurdle in the development of new 
therapies for acute ischemic stroke. The BBB is a natural barrier that keeps large 
molecules from entering the brain (Menzies et al., 1993). Even though cerebral ischemia 
causes disruption of the BBB, it occurs only after several hours of the onset. Since the 
therapeutic time window for most neuroprotective agents is less than 6 hours, all large
molecule agents cannot enter the brain from the blood stream to achieve an
effecitivelevel; and this is especially true for neurotrophins, which are endogenously
large molecule peptides or proteins (Hefti, 1997). Thus, identifying new strategies that 
can be used beyond the current time window and regulate post-ischemia inflammation or 
enhance neurorepair are critically needed. Various research studies as well as clinical 
trials have been conducted to examine the effect of various anti-inflammatory treatments 
after ischemic stroke. While these studies offer promising avenues for anti-inflammation 
in acute ischemic stroke, the fact that blocking post-ischemic inflammation could also 
eliminate any beneficial effects of inflammation cannot be overlooked (Tobin et al., 
2014). For example, chronic inflammation induced by status epilepticus was implicated 
in increasing the number of mature neurons, the majority of which replaced dead granule 
cells in the granular cell layer of dentate gyrus (Morrens et al., 2012). In contrast, there is 
substantial evidence to show that inflammation impairs neurogenesis after injury via 
increased activation of ED1+ microglia and via secretion of numerous proinflammatory 
cytokines, including TNF-??? ???? ??????????-? (Ekdahl et al., 2003; Monje et al., 2003).
The link between the immune response that occurs after ischemic stroke, and 
neurogenesis or subsequent functional recovery has not been well established. The dual 
roles of microglia after stroke are becoming increasingly apparent, and it would appear
that the microglial response has both beneficial and detrimental consequences for 
neurogenesis (Ekdahl et al., 2009).
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As discussed in previous sections, MANF has been shown to have immunomodulation 
effects to improve the success of cell-replacement regenerative therapies in the mouse 
model of degenerative retina (Neves et al., 2016). This might result in a faster clearance 
of dead cells to improve a microenvironment. Furthermore, in my present study, MANF 
is demonstrated to be indispensable for neurite outgrowth and neuronal migration during 
cortical development. Application of exogenous MANF can promote NSC differentiation
in vitro as well as NPC migration toward the infarct boundary. Taken together, these 
findings suggest that MANF could serve as a potential pharmacological agent to boost 
functional recovery afterf ischemic injury via regulating post-ischemia inflammation and 
enhancing neuroregeneration. Further studies should be done to explore the molecular 
mechanisms involved in MANF’s regulation of these processes, which may lead to the 
development of more efficient therapeutic approaches for stroke patients. Also, it is 
anticipated that combination therapies using MANF and others groups of neurotrophic 
factors would have additive or synergistic effects in the future treatment of ischemic 
stroke.
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7 CONCLUSIONS
This thesis aimed to elucidate the role of MANF in the developing cortex and to 
investigate the effects of neurotrophic factors on NSC/NPC survival, proliferation, 
differentiation, and migration under physiological or pathological conditions. Based on 
the findings presented in this thesis, the following conclusions can be drawn:
? MANF is expressed in NSCs/NPCs, but loss of MANF has no effects on proliferation 
or survival of NSCs/NPCs.
? It is indispensable for neurite outgrowth and regulates UPR signals during neuronal
differentiation.
? MANF is a major factor regulating cortical development in vivo and its loss results in 
delayed neuron subtype determination, decreased neurite extension, and slower 
neuronal migration.
? Administration of exogenous MANF triggers NSC differentiation accompanied by 
increased neuronal- as well as glial-related cytoskeletal proteins, and facilitates cell 
migration from SVZ explants. 
? Overexpression of MANF induces the phosphorylation of STAT3 and ERK1/2 during 
SVZ cell migration.
? MANF promotes the migration of neuroblasts toward the ischemic cortex and further 
contributes to their recruitment within infarcted neocortex.
? Endogenous MANF has a neuroprotective effect in a mouse model of permanent 
cortical ischemia.
? Although GDNF increased proliferation of SVZ cells after stroke, it did not 
significantly promote the migration of neuroblasts towards ischemic cortex or 
improve functional recovery.
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? Focal delivery of AAV2-BDNF to the non-lesioned side of the SVZ increases 
migration of NPCs in SVZ and improves behavioral function in stroke animals.
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